≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Molar incisor enamel hypoplasia, with caries

Endpoint Browser PheWeb

K11_MIH_CARIES

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

  • K11_CARIES
14444

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

3 out of 7 registries used, show all original rules.

316

4. Check minimum number of events

None

316

5. Include endpoints

316

6. Filter based on genotype QC (FinnGen only)

286

Control definitions (FinnGen only)

Control conditions
not K11_CARIES

Extra metadata

First used in FinnGen datafreeze
DF10

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2382 1118 1261
Only index persons 1584 754 830
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.04
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 8.86 8.93 8.74
Only index persons 11.23 11.43 11.04

-FinnGen-

Key figures

All Female Male
Number of individuals 286 152 134
Unadjusted period prevalence (%) 0.06 0.05 0.06
Median age at first event (years) 9.02 9.53 8.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
316
Matched controls
3133
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
599.6
307.7
304
127
127
Kela drug reimbursment
Transplant complication
143.0
232.0
118
13
H02AB09
ATC
hydrocortisone; systemic
37.5
206.1
147
71
EBA15
NOMESCO Finland
Extraction of multiple teeth
89.9
192.4
104
17
L04AD02
ATC
tacrolimus; systemic
118.7
191.1
99
12
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
49.2
190.3
119
38
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
40.1
183.5
123
49
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
36.5
172.6
119
51
Z94.0
ICD-10 Finland
Kidney transplant status
87.3
164.8
89
14
H02AB04
ATC
methylprednisolone; systemic
29.5
152.1
113
58
L04AX01
ATC
azathioprine; systemic
29.9
144.9
106
52
A11CC03
ATC
alfacalcidol; systemic
46.1
142.0
88
26
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
17.4
140.2
150
155
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
67.0
136.5
77
15
L04AD01
ATC
ciclosporin; systemic
43.6
130.8
82
25
L04AA06
ATC
mycophenolic acid; systemic
51.0
125.3
75
19
Z2221
NOMESCO Finland
Medical doctor
15.7
122.0
247
582
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
65.8
120.5
68
13
ZX120
NOMESCO Finland
Intravenous
15.9
120.0
128
129
XF602
NOMESCO Finland
Bloodpressure monitoring
43.7
115.8
72
21
K03.66
ICD-10 Finland
Tooth plaque
11.9
111.3
208
436
WX404
NOMESCO Finland
Intravenous generell anesthesy
13.2
110.4
238
587
205
Kela drug reimbursment
Chronic hypertension
23.6
108.1
85
48
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
15.4
105.8
110
105
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
65.2
104.7
59
11
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
21.4
103.1
85
53
ZXE10
NOMESCO Finland
More than one and less than three hours
12.1
102.6
236
614
A12AA04
ATC
calcium carbonate; oral
63.8
102.5
58
11
ZXD05
NOMESCO Finland
Urgent procedure
10.4
100.2
193
410
C08CA01
ATC
amlodipine; oral
16.6
98.9
95
79
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
10.8
98.3
150
242
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
13.4
97.9
112
123
K06.18
ICD-10 Finland
Another gingival hyperplasia
54.8
94.3
55
12
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
38.1
89.0
57
18
ZXE20
NOMESCO Finland
More than three and less than five hours
10.2
88.6
134
211
602
Kela drug reimbursment
Children's severe malnutrition
14.5
87.8
91
85
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
9.4
87.3
150
274
Z3226
NOMESCO Finland
Physiotherapist
9.4
86.5
218
599
Z2446
NOMESCO Finland
Social worker
8.8
85.8
184
427
A41.9
ICD-10 Finland
Sepsis, unspecified
21.2
84.1
68
40
C03CA01
ATC
furosemide; systemic
15.6
84.1
82
69
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
29.1
82.8
58
24
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
24.4
82.3
62
31
R4110
NOMESCO Finland
Physiotherapy
9.0
82.2
220
635
WX408
NOMESCO Finland
General anesthesy, balanced
9.4
82.2
231
701
K03.00
ICD-10 Finland
Approximal wear
12.2
80.6
95
107
K02.0
ICD-10 Finland
Caries limited to enamel
16.3
80.2
283
1078
TK800
NOMESCO Finland
Hemodialysis
53.2
78.6
46
10
Z3229
NOMESCO Finland
Other healthcare associate professional
8.7
76.3
132
239
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.4
76.0
221
680
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.8
75.4
184
476
TPH07
NOMESCO Finland
Cathetrisation of artery
9.3
75.2
116
184
ZXD10
NOMESCO Finland
Scheduled procedure
9.3
72.7
248
881
TPH04
NOMESCO Finland
Cathetrisation of vein
7.8
71.7
145
308
N18.8
ICD-10 Finland
Other chronic renal failure
32.0
69.9
47
17
TPX10
NOMESCO Finland
Implantation of vascular injection port
24.5
69.8
52
25
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
41.0
69.0
43
12
XW000
NOMESCO Finland
Bone marrow biopsy
17.8
67.6
59
40
ZXA00
NOMESCO Finland
Right side
7.7
65.6
124
243
V03AG01
ATC
sodium cellulose phosphate; systemic
36.8
65.4
42
13
Z01.0
ICD-10 Finland
Examination of eyes and vision
6.8
64.6
173
476
K03.28
ICD-10 Finland
Other erosion of teeth
22.8
64.0
49
25
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
6.9
63.9
150
364
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
13.9
61.6
62
54
XF400
NOMESCO Finland
ECG with 12 standard connections
6.5
61.4
165
452
ZXE00
NOMESCO Finland
One hour or less
7.9
60.7
248
987
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
9.6
60.6
83
112
FM2CE, ,
NOMESCO Finland
7.7
60.4
108
198
ZX199
NOMESCO Finland
Other rote
25.2
60.2
44
20
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
10.8
59.2
72
83
C07AB02
ATC
metoprolol; systemic
12.0
58.4
65
66
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
96.7
58.3
63
8
RD210, ,
NOMESCO Finland
7.9
58.1
98
168
SAA04
NOMESCO Finland
Special examination of mouth
6.6
56.1
125
284
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
7.6
55.6
97
172
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
11.3
52.8
61
65
Z3231
NOMESCO Finland
Registered nurse
6.8
52.6
244
1040
Z2445
NOMESCO Finland
Psychologist
6.0
51.9
128
317
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
21.5
51.4
40
21
WX882
NOMESCO Finland
High dependency care
6.2
51.3
118
274
WW500
NOMESCO Finland
Blood transfusion
12.1
51.2
56
55
137
Kela drug reimbursment
Uraemia requiring dialysis
83.9
50.8
56
8
WX402
NOMESCO Finland
General anaesthesia
5.5
50.8
175
577
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
5.7
50.2
137
370
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.2
50.0
77
118
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.6
49.9
102
211
SCE00
NOMESCO Finland
Fissure sealant
5.3
48.7
176
599
B03XA01
ATC
erythropoietin; parenteral
89.5
48.5
53
7
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
17.0
48.1
42
28
R50.9
ICD-10 Finland
Fever, unspecified
5.2
47.9
173
587
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
12.4
47.8
51
48
TAB00
NOMESCO Finland
Lumbar puncture
10.8
47.6
56
61
C09AA02
ATC
enalapril; systemic
11.5
47.1
53
54
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
15.9
46.3
42
30
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.3
46.1
143
426
ZXA05
NOMESCO Finland
Left side
6.3
45.9
98
210
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
19.7
45.8
37
21
C03DA01
ATC
spironolactone; oral
11.2
45.6
52
54
Z94.4
ICD-10 Finland
Liver transplant status
+∞
44.7
42
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.3
43.9
90
185
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.9
43.6
80
147
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
106.4
42.9
46
5
B05DA
ATC
Isotonic solutions
106.4
42.9
46
5
L04AA01
ATC
[U] ciclosporin
77.8
42.2
47
7
ZXA10
NOMESCO Finland
Bilateral
5.0
41.8
128
373
B01AA03
ATC
warfarin; systemic
14.6
41.2
39
30
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
10.3
40.5
49
55
Z49.2
ICD-10 Finland
Other dialysis
119.6
39.7
42
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
6.5
38.9
75
144
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
6.7
37.6
69
126
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
6.0
37.2
79
166
C09CA01
ATC
losartan; oral
10.0
36.8
45
51
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
5.0
36.2
101
269
RS220, ,
NOMESCO Finland
9.5
36.2
46
55
SAA03
NOMESCO Finland
Extended examination of mouth
8.7
36.0
288
1693
XX4AW, ,
NOMESCO Finland
8.3
35.5
51
71
201
Kela drug reimbursment
Chronic cardiac insufficiency
12.9
35.4
36
31
C08CA02
ATC
felodipine; oral
58.1
35.3
41
8
R4190
NOMESCO Finland
Nutritional therapy
4.4
34.6
123
395
Z49.1
ICD-10 Finland
Extracorporeal dialysis
85.0
34.6
38
5
B05DB
ATC
Hypertonic solutions
372.3
34.5
34
*
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
103.5
34.4
37
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
62.7
34.0
39
7
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
62.7
34.0
39
7
ZXE40
NOMESCO Finland
More than seven and less than nine hours
9.6
33.6
42
49
XA800
NOMESCO Finland
Neuropsychological investigation
5.1
33.4
87
218
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.3
33.2
64
122
KAC00
NOMESCO Finland
Nephrectomy
45.1
32.9
40
10
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.7
32.8
45
59
5AB14, ,
NOMESCO Finland
68.9
32.7
37
6
Z99.2
ICD-10 Finland
Dependence on renal dialysis
80.1
32.5
36
5
B03XA02
ATC
darbepoetin alfa; parenteral
125.5
32.2
34
*
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
11.0
31.2
35
35
ZX114
NOMESCO Finland
Intramuscular
12.5
31.1
32
28
A05AA02
ATC
ursodeoxycholic acid; oral
13.0
30.9
31
26
RS221, ,
NOMESCO Finland
7.7
30.3
46
68
ZXD20
NOMESCO Finland
Day surgery
5.4
30.1
70
158
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.8
29.9
81
208
WW200
NOMESCO Finland
Immunization
10.7
29.7
34
35
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.7
28.9
147
594
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.5
28.2
62
133
Z94.1
ICD-10 Finland
Heart transplant status
304.7
28.1
28
*
BE00A, ,
NOMESCO Finland
109.2
28.1
30
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.8
27.9
34
38
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
11.6
27.9
30
28
TK820
NOMESCO Finland
Peritoneal dialysis
58.5
27.6
32
6
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
10.3
27.3
32
34
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
30.8
27.2
36
13
A02BC01
ATC
omeprazole; systemic
4.4
27.0
82
229
ZY010
NOMESCO Finland
Hospital outpatient
4.3
26.6
86
252
J05AB01
ATC
aciclovir; systemic
4.7
26.5
72
184
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.1
26.3
34
41
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.2
26.3
88
264
H02AB02
ATC
dexamethasone; systemic
8.7
26.3
35
44
KA1AE
NOMESCO Finland
Kidney ultrasound examination
10.5
26.0
30
31
V03AE01
ATC
polystyrene sulfonate; oral
280.0
26.0
26
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
48.5
25.9
31
7
B34.9
ICD-10 Finland
Viral infection, unspecified
4.7
25.4
69
176
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.3
25.4
58
128
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
7.6
25.3
38
55
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
8.5
24.9
34
44
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.3
24.8
77
218
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
7.1
24.7
40
63
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.3
24.5
182
907
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
72.8
24.1
27
*
EB1WA, ,
NOMESCO Finland
72.8
24.1
27
*
WX002
NOMESCO Finland
Sedation and analgesia
4.8
24.0
63
156
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.5
24.0
112
420
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
23.9
105
378
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
134.1
23.9
25
*
BC00A, ,
NOMESCO Finland
58.3
23.4
27
5
UDC00
NOMESCO Finland
Ear microscopy
4.7
23.1
62
156
ZX121
NOMESCO Finland
Central venous catheter
20.8
23.0
34
18
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.5
22.8
104
382
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.9
22.7
84
269
4AA09, ,
NOMESCO Finland
67.0
22.1
25
*
GD1AD
NOMESCO Finland
Thorax CT examination
9.3
21.6
27
31
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
3.3
21.2
116
474
XF600
NOMESCO Finland
Bloodpressure measurement
3.6
21.2
91
320
RS121, ,
NOMESCO Finland
9.1
21.1
27
32
J05AB11
ATC
valaciclovir; oral
5.5
20.8
44
90
B07.9
ICD-10 Finland
Verruca simplex
5.3
20.8
46
98
UKC02
NOMESCO Finland
Cystoscopy
7.0
20.7
33
51
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.8
20.5
75
237
NE1AA
NOMESCO Finland
Pelvis X-ray examination
9.0
20.2
26
31
K03.64
ICD-10 Finland
Dental calculus supragingival
3.0
20.2
190
1047
A04AA01
ATC
ondansetron; systemic, rectal
5.2
20.1
45
97
F43.8
ICD-10 Finland
Other reactions to severe stress
7.8
20.1
29
40
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
7.6
19.6
29
41
Z29.9
ICD-10 Finland
Prophylactic measure, unspecified
33.5
19.5
25
8
K07.24
ICD-10 Finland
Open bite
5.3
19.3
42
88
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
16.1
19.3
31
21
XF404
NOMESCO Finland
Ambulatory ECG
4.9
19.2
46
105
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.4
18.9
33
56
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
+∞
18.9
18
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
16.3
18.8
30
20
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.9
18.5
203
1193
RL140, ,
NOMESCO Finland
6.4
18.4
32
54
K02.1
ICD-10 Finland
Caries of dentine
3.2
18.4
241
1559
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.0
18.2
109
464
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
35.0
18.1
23
7
6BA02, ,
NOMESCO Finland
19.4
18.0
27
15
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
5.8
18.0
35
66
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.0
17.9
57
162
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
8.1
17.9
25
33
TFJ02
NOMESCO Finland
Muscle biopsy of heart
+∞
17.8
17
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
99.9
17.7
19
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
44.5
17.4
21
5
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.6
17.4
66
212
XKD00
NOMESCO Finland
Uroflowmetry
5.0
17.4
40
88
J01MA02
ATC
ciprofloxacin; systemic
3.8
17.4
61
186
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
5.2
17.3
38
80
R62.0
ICD-10 Finland
Delayed milestone
4.0
17.3
56
161
IEP02
NOMESCO Finland
Child-centred family therapy
4.3
17.2
49
128
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
5.0
17.1
40
89
ZX131
NOMESCO Finland
Intrathecal
52.7
17.1
20
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
21.3
16.6
24
12
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
177.5
16.6
17
*
XX4BW, ,
NOMESCO Finland
15.3
16.6
27
19
WX892
NOMESCO Finland
Monitored bed care
4.0
16.4
53
152
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.6
16.4
42
101
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
17.8
16.3
25
15
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
17.8
16.3
25
15
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.4
16.3
45
115
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.9
16.3
54
158
I15.8
ICD-10 Finland
Other secondary hypertension
31.7
16.3
21
7
A01AB09
ATC
miconazole; local oral
4.9
16.2
38
85
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.8
16.1
31
58
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.3
15.9
45
117
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
15.8
88
356
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.7
15.8
39
91
B01.9
ICD-10 Finland
Varicella without complication
5.7
15.8
31
59
A08.0
ICD-10 Finland
Rotaviral enteritis
7.3
15.8
24
35
SDA03
NOMESCO Finland
Periodontal treatment
2.7
15.6
126
620
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
166.5
15.6
16
*
K03.29
ICD-10 Finland
Erosion of teeth occupational
13.9
15.4
26
20
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
7.1
15.4
24
36
XF622
NOMESCO Finland
Measurement of minute volume of heart
18.8
15.3
23
13
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
21.2
15.3
22
11
L01BB02
ATC
mercaptopurine; oral
14.8
15.2
25
18
N18.0
ICD-10 Finland
End-stage renal disease
47.1
15.2
18
*
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.9
15.2
35
77
RK220, ,
NOMESCO Finland
16.0
15.1
24
16
Z31.5
ICD-10 Finland
Genetic counselling
3.4
15.0
61
204
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.4
14.9
62
210
A06AD11
ATC
lactulose; oral
4.9
14.9
35
78
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
4.6
14.9
38
91
R11
ICD-10 Finland
Nausea and vomiting
3.2
14.8
68
245
WX110
NOMESCO Finland
Infiltration anesthesia
3.5
14.8
271
1981
Z01.9
ICD-10 Finland
Special examination, unspecified
6.0
14.7
27
48
TK810
NOMESCO Finland
Hemofiltration
83.4
14.7
16
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.8
14.6
28
52
ZX090
NOMESCO Finland
Other technic of radiotherapy
155.6
14.5
15
*
RT150, ,
NOMESCO Finland
5.6
14.5
29
56
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.9
14.5
46
130
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
20.2
14.4
21
11
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
23.4
14.3
20
9
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.3
14.3
40
103
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
5.8
14.1
27
50
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
14.4
13.9
23
17
J02AC01
ATC
fluconazole; systemic
3.2
13.9
64
231
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.7
13.7
26
26
JAH00
NOMESCO Finland
Laparotomy
10.7
13.7
26
26
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.2
13.7
63
227
Z01.2
ICD-10 Finland
Dental examination
3.1
13.6
262
1911
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
+∞
13.6
13
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
13.6
13
*
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
+∞
13.6
13
*
TQW99
NOMESCO Finland
Other minor procedure on skin
6.4
13.4
23
38
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.4
13.4
168
999
UJF32
NOMESCO Finland
Coloscopy
3.7
13.3
45
133
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
5.4
13.3
27
53
Z85.6
ICD-10 Finland
Personal history of leukaemia
41.7
13.2
16
*
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
3.5
13.1
49
155
N19
ICD-10 Finland
Unspecified kidney failure
29.6
13.0
17
6
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.8
13.0
31
70
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
51.8
12.9
15
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
51.8
12.9
15
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
9.9
12.7
25
27
C10AA03
ATC
pravastatin; oral
18.1
12.6
19
11
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
18.1
12.6
19
11
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
12.6
87
390
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.3
12.5
26
52
Z49.0
ICD-10 Finland
Preparatory care for dialysis
134.0
12.5
13
*
130
Kela drug reimbursment
Malignant tumour
9.5
12.4
25
28
P85
ICPC
Mental retardation
5.6
12.4
24
45
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
12.3
33
82
WW409
NOMESCO Finland
Other aferesis
38.9
12.3
15
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
13.0
12.2
21
17
J01FF01
ATC
clindamycin; systemic
3.2
12.2
54
189
WX704
NOMESCO Finland
Intubation
4.1
12.2
36
96
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
9.8
12.1
24
26
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
18.8
12.1
18
10
L03AA02
ATC
filgrastim; parenteral
18.8
12.1
18
10
C08CA05
ATC
nifedipine; systemic
27.7
12.1
16
6
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
22.2
12.1
17
8
1AB02, ,
NOMESCO Finland
14.0
12.1
20
15
AA1AD
NOMESCO Finland
CT of head and brain
3.4
12.0
47
153
RK110, ,
NOMESCO Finland
12.3
11.9
21
18
K65.0
ICD-10 Finland
Acute peritonitis
48.2
11.9
14
*
H26.3
ICD-10 Finland
Drug-induced cataract
48.2
11.9
14
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.5
11.9
92
435
R1260
NOMESCO Finland
Evaluation of communicative skills
6.1
11.8
21
36
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
9.7
11.6
23
25
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
23.8
11.6
16
7
A28
ICPC
Limited function/disability NOS
3.3
11.5
48
162
RS222, ,
NOMESCO Finland
5.1
11.5
25
52
V03AE02
ATC
sevelamer; oral
123.3
11.5
12
*
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
123.3
11.5
12
*
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
2.4
11.4
103
521
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.2
11.4
51
180
3A013, ,
NOMESCO Finland
36.2
11.3
14
*
H52.0
ICD-10 Finland
Hypermetropia
3.6
11.2
40
122
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
25.9
11.2
15
6
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
9.7
11.1
22
24
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
2.6
11.0
76
338
J01MA12
ATC
levofloxacin; systemic
5.3
11.0
23
46
IEP03
NOMESCO Finland
Focused parental counselling
3.4
11.0
42
134
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.8
11.0
62
249
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
10.9
32
85
U14
ICPC
Kidney symptom/complaint
16.1
10.9
17
11
K00.68
ICD-10 Finland
Other disturbance in the tooth eruption
3.3
10.9
45
151
L04AX03
ATC
methotrexate; systemic
3.6
10.8
38
115
C07AG02
ATC
carvedilol; oral
61.6
10.7
12
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
10.6
118
650
ZX112
NOMESCO Finland
Subcutaneous
9.6
10.6
21
23
RL130, ,
NOMESCO Finland
4.9
10.5
24
52
N02AX02
ATC
tramadol; systemic, rectal
3.0
10.5
51
188
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
10.5
91
450
J01EA01
ATC
trimethoprim; systemic
3.0
10.5
53
200
ZX197, ,
NOMESCO Finland
+∞
10.4
10
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
10.4
10
*
K00.50
ICD-10 Finland
Dentinal dysplasia
9.2
10.4
21
24
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
7.8
10.3
23
31
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
19.4
10.3
15
8
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
24.1
10.3
14
6
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
3.8
10.2
33
94
TJD20
NOMESCO Finland
Change of gastrostomy tube
8.8
10.2
21
25
RT160, ,
NOMESCO Finland
5.5
10.1
20
38
WZC30
NOMESCO Finland
Teaching
3.0
10.0
47
170
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.7
10.0
267
2085
783, ,
NOMESCO Finland
41.1
10.0
12
*
WW400
NOMESCO Finland
Plasmaferesis
41.1
10.0
12
*
SFA10
NOMESCO Finland
One-surface restoration
2.2
10.0
202
1402
1XC02, ,
NOMESCO Finland
26.8
9.8
13
5
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.7
9.8
23
51
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
7.7
9.8
22
30
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.2
9.8
42
144
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.6
9.7
66
290
H66.9
ICD-10 Finland
Otitis media, unspecified
2.2
9.7
132
783
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
56.3
9.7
11
*
H02AB07
ATC
prednisone; oral
5.0
9.6
21
44
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
9.5
177
1181
SDA02
NOMESCO Finland
Periodontal treatment, brief
2.1
9.5
153
967
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
3.5
9.5
34
104
YNB20
NOMESCO Finland
Storage of stem cells for transplant
102.1
9.4
10
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
102.1
9.4
10
*
61
HP
Catheterization and pressure measurement of the left side of the heart
102.1
9.4
10
*
K06.10
ICD-10 Finland
Gingival fibromatosis
102.1
9.4
10
*
GD1LA
NOMESCO Finland
GD
102.1
9.4
10
*
G04BE03
ATC
sildenafil; oral
12.8
9.4
16
13
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
+∞
9.4
9
*
2AX05, ,
NOMESCO Finland
+∞
9.4
9
*
N03AX14
ATC
levetiracetam; systemic
3.8
9.3
30
85
H01AC01
ATC
somatropin; parenteral
3.3
9.3
37
121
WX722
NOMESCO Finland
PEEP
4.4
9.2
24
58
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
14.1
9.2
15
11
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.7
9.2
30
86
A02BC05
ATC
esomeprazole; systemic
2.6
9.1
59
253
TJF80
NOMESCO Finland
Ostomy education
9.4
9.1
18
20
RK230, ,
NOMESCO Finland
9.4
9.1
18
20
RS224, ,
NOMESCO Finland
4.8
9.1
21
46
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.0
9.1
20
42
XG410
NOMESCO Finland
Flow-volume spirometry
3.7
9.0
30
87
1XX02, ,
NOMESCO Finland
37.5
9.0
11
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
24.6
8.9
12
5
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
8.3
8.9
19
24
7AX01, ,
NOMESCO Finland
12.9
8.9
15
12
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
3.5
8.9
32
98
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.9
8.9
18
21
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.1
8.7
194
1366
Z94.2
ICD-10 Finland
Lung transplant status
51.0
8.7
10
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
51.0
8.7
10
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
16.7
8.6
13
8
JAF10
NOMESCO Finland
Repair of umbilical hernia
10.4
8.6
16
16
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
28.1
8.5
11
*
L04AA05
ATC
[U] tacrolimus
91.6
8.4
9
*
RS210, ,
NOMESCO Finland
13.1
8.4
14
11
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.2
8.4
35
118
N0480, Z940,
ICD-10 Finland
+∞
8.3
8
*
RK320, ,
NOMESCO Finland
11.1
8.3
15
14
RK260, ,
NOMESCO Finland
11.1
8.3
15
14
B01AB05
ATC
enoxaparin; parenteral
3.5
8.3
30
92
L28
ICPC
Limited function/disability (L)
3.1
8.3
36
124
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
8.3
24
63
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
14.9
8.2
13
9
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
7.8
8.2
18
24
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.4
8.2
21
50
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.6
8.2
51
214
Q20.48
ICD-10 Finland
Single ventricle
17.6
8.1
12
7
Q44.29
ICD-10 Finland
Atresia of bile ducts
34.0
8.1
10
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
34.0
8.1
10
*
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
34.0
8.1
10
*
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.8
8.1
25
69
F40.2
ICD-10 Finland
Specific (isolated) phobias
10.3
8.1
15
15
ZYC01
NOMESCO Finland
Remote contact by phone
2.9
8.1
40
149
E34.35
ICD-10 Finland
Abnormal growth retardation
3.2
8.0
33
110
TPX15
NOMESCO Finland
Removal of vascular injection port
22.5
8.0
11
5
K83.0
ICD-10 Finland
Cholangitis
13.4
7.9
13
10
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
8.7
7.9
16
19
J01DB01
ATC
cefalexin; oral
2.1
7.8
236
1820
ZX100
NOMESCO Finland
Oral
9.7
7.8
15
16
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.6
7.8
19
30
WX199
NOMESCO Finland
Other local analgesia
15.4
7.7
12
8
SCF01
NOMESCO Finland
Preventive oral care by dental hygienist or dental assistant, restricted
2.6
7.7
47
195
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
45.7
7.7
9
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.3
7.6
16
20
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
18.8
7.6
11
6
324, ,
NOMESCO Finland
18.8
7.6
11
6
Z71.8
ICD-10 Finland
Other specified counselling
2.0
7.6
138
891
H52.2
ICD-10 Finland
Astigmatism
3.2
7.6
31
103
RK224, ,
NOMESCO Finland
25.5
7.6
10
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
10.3
7.6
14
14
K07.22
ICD-10 Finland
Anomalies of dental arch relationship
3.1
7.5
33
115
XCK10
NOMESCO Finland
Photography of fundus of eye
4.1
7.5
21
54
N03AX16
ATC
[U] pregabalin
3.6
7.5
25
73
ZX196, ,
NOMESCO Finland
81.2
7.4
8
*
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
81.2
7.4
8
*
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
8.6
7.4
15
18
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.8
7.3
23
64
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
11.1
7.3
13
12
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.0
7.3
34
122
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
6.5
7.3
18
29
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.2
7.3
30
100
503
Kela drug reimbursment
Inborn metabolic disorders
+∞
7.3
7
*
V03AE03
ATC
lanthanum carbonate; oral
+∞
7.3
7
*
SPC10
NOMESCO Finland
Standard dental crown
+∞
7.3
7
*
Z940, N0480,
ICD-10 Finland
+∞
7.3
7
*
I15.0
ICD-10 Finland
Renovascular hypertension
+∞
7.3
7
*
RS211, ,
NOMESCO Finland
4.3
7.3
19
46
H02AB06
ATC
prednisolone; systemic
2.0
7.3
93
530
3A077, ,
NOMESCO Finland
16.1
7.2
11
7
D64.8
ICD-10 Finland
Other specified anaemias
16.1
7.2
11
7
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
7.5
7.2
16
22
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
7.5
7.2
16
22
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.4
7.2
18
42
SCA02
NOMESCO Finland
Preventive oral health care
1.9
7.2
171
1200
UJF92
NOMESCO Finland
Capsular endoscopy
4.6
7.2
17
38
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.4
7.2
26
80
JKD50
NOMESCO Finland
Hepatoportoenterostomy
30.5
7.2
9
*
3025
Kela drug reimbursment
Calcium carbonate
30.5
7.2
9
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
30.5
7.2
9
*
TK823
NOMESCO Finland
Peritoneal permeability analysis
20.4
7.1
10
5
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
20.4
7.1
10
5
A41.8
ICD-10 Finland
Other specified sepsis
20.4
7.1
10
5
NFK20
NOMESCO Finland
Epiphysiodesis of femur
20.4
7.1
10
5
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.8
7.1
19
34
AA1AA
NOMESCO Finland
Head X-ray examination
9.0
7.1
14
16
R4120
NOMESCO Finland
Occupational therapy
2.8
7.1
37
142
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.0
7.0
20
52
NF1AA
NOMESCO Finland
Hip X-ray examination
6.5
7.0
17
27
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.0
7.0
18
31
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
14.1
6.9
11
8
XX8XW, ,
NOMESCO Finland
14.1
6.9
11
8
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
3.4
6.9
25
77
TLC00
NOMESCO Finland
Insertion of intrauterine device
4.2
6.8
18
44
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
11.2
6.8
12
11
120
Kela drug reimbursment
Hypogammaglobulinaemia
40.6
6.8
8
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
40.6
6.8
8
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
40.6
6.8
8
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
2.1
6.7
74
397
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
3.5
6.7
23
68
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
4.0
6.7
19
49
DFF00
NOMESCO Finland
Pure tone audiometry
3.0
6.7
31
111
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
22.9
6.7
9
*
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
22.9
6.7
9
*
IEP04
NOMESCO Finland
Focused parenting intervention
5.7
6.7
18
33
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
5.7
6.7
18
33
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.3
6.6
56
270
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.7
6.6
21
59
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.5
6.6
23
69
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
12.5
6.6
11
9
K00.00
ICD-10 Finland
Hypodontia
2.9
6.6
31
112
A08.2
ICD-10 Finland
Adenoviral enteritis
10.3
6.6
12
12
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
2.5
6.5
42
179
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.4
6.5
16
26
F81.0
ICD-10 Finland
Specific reading disorder
3.8
6.5
20
55
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
6.5
222
1728
TKA05
NOMESCO Finland
Aspiration cytology of kidney
70.6
6.4
7
*
2AA01, ,
NOMESCO Finland
70.6
6.4
7
*
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
70.6
6.4
7
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
14.6
6.4
10
7
SPAT1262
SPAT
Handing over of treatment supplies
2.7
6.3
36
144
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
2.7
6.3
34
132
C10AA05
ATC
atorvastatin; oral
3.5
6.3
22
66
RK310, ,
NOMESCO Finland
9.5
6.3
12
13
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
18.3
6.3
9
5
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.0
6.3
18
47
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.6
6.3
36
145
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
+∞
6.2
6
*
H05BX01
ATC
cinacalcet; oral
+∞
6.2
6
*
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
+∞
6.2
6
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
6.2
6
*
Q61.41
ICD-10 Finland
Renal dysplasia of both kidneys (multicystic)
+∞
6.2
6
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
6.2
6
*
M81.8
ICD-10 Finland
Other osteoporosis
+∞
6.2
6
*
JJC50
NOMESCO Finland
Resection of transplanted liver
+∞
6.2
6
*
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
27.0
6.2
8
*
R18
ICD-10 Finland
Ascites
27.0
6.2
8
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
27.0
6.2
8
*
SAB02
NOMESCO Finland
Oral and dental health check by dental hygienist or dental assistant
0.5
6.2
67
1107
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
3.8
6.2
19
52
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
2.6
6.2
38
158
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
5.5
6.2
17
32
R4140
NOMESCO Finland
Psychotherapy
12.7
6.1
10
8
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
8.8
6.1
12
14
R5120
NOMESCO Finland
Preparation of an aid
8.8
6.1
12
14
RK210, ,
NOMESCO Finland
10.2
6.0
11
11

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Kidney transplant status
Z94.0 [45566477]
—
4.7e+00
4.0e+00
—
4.2e+00
4.7e+00
4.7e+00
—
—
cases:18.33%
controls:0.21%
cases:10.36%
controls:0.21%
—
—
cases:12.35%
controls:0.21%
cases:20.16%
controls:0.22%
cases:21.78%
controls:0.26%
—
46
5
205
2356
26
5
225
2356
—
31
5
220
2349
49
5
194
2277
44
5
158
1903
Medical doctor
Z2221 [2001311556]
2.4e+00
3.1e+00
2.5e+00
1.0e+50
3.7e+00
3.3e+00
3.5e+00
cases:42.92%
controls:6.15%
cases:29.88%
controls:1.86%
cases:5.58%
controls:0.47%
cases:29.48%
controls:0.00%
cases:9.16%
controls:0.25%
cases:30.04%
controls:1.53%
cases:47.03%
controls:2.52%
103
139
137
2122
75
44
176
2317
14
11
237
2350
74
0
177
2361
23
6
228
2348
73
35
170
2247
95
48
107
1860
methylprednisolone; oral, parenteral
H02AB04 [21602732]
4.4e+00
4.7e+00
—
—
—
4.8e+00
4.6e+00
cases:21.67%
controls:0.35%
cases:25.10%
controls:0.30%
—
—
—
—
—
—
cases:24.69%
controls:0.26%
cases:28.71%
controls:0.42%
52
8
188
2253
63
7
188
2354
—
—
—
60
6
183
2276
58
8
144
1900
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
2.8e+00
3.7e+00
—
1.0e+50
3.2e+00
3.6e+00
4.6e+00
cases:9.58%
controls:0.62%
cases:13.15%
controls:0.38%
—
—
cases:4.78%
controls:0.00%
cases:4.78%
controls:0.21%
cases:11.93%
controls:0.35%
cases:26.24%
controls:0.37%
23
14
217
2247
33
9
218
2352
—
12
0
239
2361
12
5
239
2349
29
8
214
2274
53
7
149
1901
Pediatric Nephrology
OMOP4822026 [45756813]
2.6e+00
2.9e+00
2.5e+00
—
3.4e+00
3.1e+00
3.2e+00
cases:20.00%
controls:1.90%
cases:21.91%
controls:1.48%
cases:5.98%
controls:0.51%
—
—
cases:9.96%
controls:0.38%
cases:21.81%
controls:1.27%
cases:31.19%
controls:1.89%
48
43
192
2218
55
35
196
2326
15
12
236
2349
—
25
9
226
2345
53
29
190
2253
63
36
139
1872
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
2.8e+00
3.4e+00
—
1.0e+50
2.7e+00
3.6e+00
4.3e+00
cases:8.33%
controls:0.57%
cases:12.35%
controls:0.47%
—
—
cases:4.38%
controls:0.00%
cases:3.59%
controls:0.25%
cases:12.76%
controls:0.39%
cases:25.25%
controls:0.47%
20
13
220
2248
31
11
220
2350
—
11
0
240
2361
9
6
242
2348
31
9
212
2273
51
9
151
1899
calcium (different salts in combination); oral
A12AA20 [21600872]
2.7e+00
3.0e+00
2.3e+00
—
2.6e+00
2.8e+00
3.1e+00
cases:19.17%
controls:1.55%
cases:15.54%
controls:0.93%
cases:3.19%
controls:0.34%
—
—
cases:3.98%
controls:0.30%
cases:13.58%
controls:0.96%
cases:24.75%
controls:1.42%
46
35
194
2226
39
22
212
2339
8
8
243
2353
—
10
7
241
2347
33
22
210
2260
50
27
152
1881
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.8e+00
2.4e+00
3.1e+00
1.0e+50
2.9e+00
3.0e+00
3.1e+00
cases:20.00%
controls:3.98%
cases:17.93%
controls:1.86%
cases:5.98%
controls:0.30%
cases:4.78%
controls:0.00%
cases:6.77%
controls:0.38%
cases:20.58%
controls:1.23%
cases:33.17%
controls:2.15%
48
90
192
2171
45
44
206
2317
15
7
236
2354
12
0
239
2361
17
9
234
2345
50
28
193
2254
67
41
135
1867
azathioprine; oral, parenteral
L04AX01 [21603927]
3.6e+00
3.9e+00
—
—
—
4.3e+00
4.5e+00
cases:18.75%
controls:0.62%
cases:18.73%
controls:0.47%
—
—
—
—
—
—
cases:20.99%
controls:0.35%
cases:25.25%
controls:0.37%
45
14
195
2247
47
11
204
2350
—
—
—
51
8
192
2274
51
7
151
1901
Pediatric Hematology-Oncology
OMOP4822028 [45756811]
2.1e+00
2.6e+00
3.0e+00
—
3.1e+00
2.6e+00
2.9e+00
cases:17.08%
controls:2.48%
cases:15.94%
controls:1.36%
cases:8.76%
controls:0.47%
—
—
cases:7.57%
controls:0.38%
cases:14.81%
controls:1.27%
cases:21.29%
controls:1.52%
41
56
199
2205
40
32
211
2329
22
11
229
2350
—
19
9
232
2345
36
29
207
2253
43
29
159
1879
More than one and less than three hours
ZXE10 [2001311401]
2.2e+00
2.6e+00
2.4e+00
1.0e+50
3.5e+00
3.0e+00
2.5e+00
cases:43.75%
controls:7.92%
cases:20.32%
controls:1.91%
cases:2.79%
controls:0.25%
cases:3.19%
controls:0.00%
cases:6.37%
controls:0.21%
cases:15.23%
controls:0.92%
cases:27.23%
controls:3.04%
105
179
135
2082
51
45
200
2316
7
6
244
2355
8
0
243
2361
16
5
235
2349
37
21
206
2261
55
58
147
1850
Acute lymphoblastic leukaemia [ALL]
C91.0 [45537873]
3.2e+00
3.1e+00
3.2e+00
—
—
3.2e+00
3.3e+00
cases:8.33%
controls:0.35%
cases:7.57%
controls:0.38%
cases:4.78%
controls:0.21%
—
—
—
—
cases:7.00%
controls:0.31%
cases:9.41%
controls:0.37%
20
8
220
2253
19
9
232
2352
12
5
239
2356
—
—
17
7
226
2275
19
7
183
1901
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.7e+00
2.2e+00
2.9e+00
—
3.2e+00
2.5e+00
2.9e+00
cases:25.00%
controls:5.57%
cases:22.71%
controls:3.05%
cases:8.76%
controls:0.51%
—
—
cases:9.16%
controls:0.42%
cases:20.58%
controls:2.10%
cases:35.15%
controls:2.78%
60
126
180
2135
57
72
194
2289
22
12
229
2349
—
23
10
228
2344
50
48
193
2234
71
53
131
1855
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2.0e+00
2.4e+00
2.9e+00
1.0e+50
3.1e+00
2.5e+00
2.6e+00
cases:18.33%
controls:3.01%
cases:18.33%
controls:2.08%
cases:5.58%
controls:0.34%
cases:3.59%
controls:0.00%
cases:6.37%
controls:0.30%
cases:17.28%
controls:1.75%
cases:29.70%
controls:2.94%
44
68
196
2193
46
49
205
2312
14
8
237
2353
9
0
242
2361
16
7
235
2347
42
40
201
2242
60
56
142
1852
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
2.0e+00
2.3e+00
3.0e+00
—
2.9e+00
2.5e+00
2.6e+00
cases:22.50%
controls:3.80%
cases:23.11%
controls:2.88%
cases:11.16%
controls:0.64%
—
—
cases:8.76%
controls:0.51%
cases:21.40%
controls:2.28%
cases:34.16%
controls:3.56%
54
86
186
2175
58
68
193
2293
28
15
223
2346
—
22
12
229
2342
52
52
191
2230
69
68
133
1840
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.5e+00
2.1e+00
2.7e+00
1.0e+50
2.7e+00
2.5e+00
2.8e+00
cases:22.08%
controls:5.84%
cases:16.33%
controls:2.24%
cases:4.78%
controls:0.34%
cases:2.79%
controls:0.00%
cases:4.38%
controls:0.30%
cases:11.93%
controls:1.14%
cases:24.26%
controls:1.89%
53
132
187
2129
41
53
210
2308
12
8
239
2353
7
0
244
2361
11
7
240
2347
29
26
214
2256
49
36
153
1872
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.5e+00
2.2e+00
2.6e+00
—
2.9e+00
2.5e+00
2.5e+00
cases:17.50%
controls:4.56%
cases:17.53%
controls:2.29%
cases:5.18%
controls:0.42%
—
—
cases:5.18%
controls:0.30%
cases:16.46%
controls:1.62%
cases:31.68%
controls:3.67%
42
103
198
2158
44
54
207
2307
13
10
238
2351
—
13
7
238
2347
40
37
203
2245
64
70
138
1838
Outpatient Visit
OP [9202]
1.9e+00
1.6e+00
1.6e+00
4.4e+00
1.7e+00
1.4e+00
1.4e+00
cases:97.08%
controls:83.06%
cases:86.06%
controls:55.27%
cases:42.23%
controls:12.41%
cases:38.65%
controls:0.76%
cases:45.42%
controls:12.66%
cases:81.48%
controls:52.98%
cases:95.54%
controls:83.65%
233
1878
7
383
216
1305
35
1056
106
293
145
2068
97
18
154
2343
114
298
137
2056
198
1209
45
1073
193
1596
9
312
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.5e+00
2.0e+00
2.7e+00
—
2.8e+00
2.4e+00
2.6e+00
cases:28.33%
controls:8.14%
cases:23.51%
controls:4.15%
cases:8.37%
controls:0.64%
—
—
cases:8.76%
controls:0.55%
cases:23.05%
controls:2.76%
cases:39.60%
controls:4.72%
68
184
172
2077
59
98
192
2263
21
15
230
2346
—
22
13
229
2341
56
63
187
2219
80
90
122
1818
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.7e+00
2.2e+00
2.1e+00
—
2.6e+00
2.6e+00
2.4e+00
cases:10.00%
controls:1.99%
cases:10.36%
controls:1.27%
cases:2.39%
controls:0.30%
—
—
cases:2.79%
controls:0.21%
cases:11.11%
controls:0.88%
cases:22.28%
controls:2.46%
24
45
216
2216
26
30
225
2331
6
7
245
2354
—
7
5
244
2349
27
20
216
2262
45
47
157
1861
amlodipine; oral
C08CA01 [21601747]
2.0e+00
2.4e+00
—
—
2.7e+00
2.4e+00
4.0e+00
cases:8.33%
controls:1.19%
cases:8.37%
controls:0.85%
—
—
—
—
cases:3.59%
controls:0.25%
cases:8.23%
controls:0.79%
cases:16.34%
controls:0.37%
20
27
220
2234
21
20
230
2341
—
—
9
6
242
2348
20
18
223
2264
33
7
169
1901
pH of Serum or Plasma
2753-2 [3018418]
1.5e+00
2.3e+00
3.1e+00
—
2.1e+00
2.3e+00
1.9e+00
cases:16.25%
controls:4.02%
cases:13.94%
controls:1.52%
cases:4.38%
controls:0.21%
—
—
cases:2.39%
controls:0.30%
cases:14.40%
controls:1.67%
cases:22.77%
controls:4.19%
39
91
201
2170
35
36
216
2325
11
5
240
2356
—
6
7
245
2347
35
38
208
2244
46
80
156
1828
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
1.5e+00
1.9e+00
2.6e+00
1.0e+50
2.6e+00
2.4e+00
2.4e+00
cases:26.25%
controls:7.70%
cases:21.12%
controls:3.85%
cases:7.17%
controls:0.59%
cases:2.79%
controls:0.00%
cases:5.98%
controls:0.47%
cases:16.46%
controls:1.84%
cases:27.72%
controls:3.46%
63
174
177
2087
53
91
198
2270
18
14
233
2347
7
0
244
2361
15
11
236
2343
40
42
203
2240
56
66
146
1842
Physiotherapy
R4110 [2001310233]
1.9e+00
1.8e+00
2.3e+00
1.0e+50
2.3e+00
2.2e+00
2.5e+00
cases:34.58%
controls:7.21%
cases:18.73%
controls:3.60%
cases:4.78%
controls:0.51%
cases:1.99%
controls:0.00%
cases:5.58%
controls:0.59%
cases:22.63%
controls:3.11%
cases:35.64%
controls:4.40%
83
163
157
2098
47
85
204
2276
12
12
239
2349
5
0
246
2361
14
14
237
2340
55
71
188
2211
72
84
130
1824
metoprolol; oral, parenteral
C07AB02 [21601684]
2.6e+00
3.2e+00
—
—
—
3.1e+00
4.1e+00
cases:7.92%
controls:0.66%
cases:7.57%
controls:0.34%
—
—
—
—
—
—
cases:7.41%
controls:0.35%
cases:13.37%
controls:0.26%
19
15
221
2246
19
8
232
2353
—
—
—
18
8
225
2274
27
5
175
1903
sulfadiazine and trimethoprim
J01EE02 [21602962]
1.6e+00
2.1e+00
2.8e+00
—
2.7e+00
2.1e+00
1.6e+00
cases:35.00%
controls:10.08%
cases:20.32%
controls:2.96%
cases:6.77%
controls:0.42%
—
—
cases:5.18%
controls:0.38%
cases:13.17%
controls:1.84%
cases:16.34%
controls:3.83%
84
228
156
2033
51
70
200
2291
17
10
234
2351
—
13
9
238
2345
32
42
211
2240
33
73
169
1835
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
1.3e+00
1.9e+00
2.6e+00
1.0e+50
2.7e+00
2.2e+00
2.1e+00
cases:21.67%
controls:6.77%
cases:14.74%
controls:2.54%
cases:4.38%
controls:0.34%
cases:1.99%
controls:0.00%
cases:4.78%
controls:0.34%
cases:9.47%
controls:1.14%
cases:18.81%
controls:2.73%
52
153
188
2108
37
60
214
2301
11
8
240
2353
5
0
246
2361
12
8
239
2346
23
26
220
2256
38
52
164
1856
General anesthesia, balanced
WX408 [2001310808]
1.7e+00
2.1e+00
2.4e+00
1.0e+50
3.0e+00
1.8e+00
1.8e+00
cases:37.08%
controls:10.08%
cases:17.93%
controls:2.63%
cases:2.39%
controls:0.21%
cases:1.99%
controls:0.00%
cases:4.78%
controls:0.25%
cases:9.05%
controls:1.58%
cases:24.26%
controls:4.87%
89
228
151
2033
45
62
206
2299
6
5
245
2356
5
0
246
2361
12
6
239
2348
22
36
221
2246
49
93
153
1815
Caries limited to enamel
K02.0 [45576967]
1.9e+00
2.0e+00
—
1.0e+50
3.7e+00
2.8e+00
2.3e+00
cases:24.17%
controls:4.51%
cases:16.33%
controls:2.46%
—
—
cases:39.84%
controls:0.00%
cases:10.76%
controls:0.30%
cases:28.81%
controls:2.45%
cases:57.92%
controls:12.16%
58
102
182
2159
41
58
210
2303
—
100
0
151
2361
27
7
224
2347
70
56
173
2226
117
232
85
1676
Scheduled procedure
ZXD10 [2001311387]
2.1e+00
2.2e+00
2.4e+00
1.0e+50
—
3.1e+00
2.9e+00
cases:49.17%
controls:10.75%
cases:21.12%
controls:2.92%
cases:4.38%
controls:0.42%
cases:2.79%
controls:0.00%
—
—
cases:16.87%
controls:0.88%
cases:25.25%
controls:1.89%
118
243
122
2018
53
69
198
2292
11
10
240
2351
7
0
244
2361
—
41
20
202
2262
51
36
151
1872
Office Visit
OMOP4822458 [581477]
1.7e+00
1.9e+00
1.8e+00
—
3.0e+00
2.0e+00
2.2e+00
cases:48.33%
controls:14.29%
cases:23.51%
controls:4.45%
cases:3.59%
controls:0.59%
—
—
cases:9.16%
controls:0.51%
cases:26.34%
controls:4.51%
cases:46.04%
controls:8.86%
116
323
124
1938
59
105
192
2256
9
14
242
2347
—
23
12
228
2342
64
103
179
2179
93
169
109
1739
Physiotherapist
Z3226 [2001311560]
1.8e+00
2.5e+00
2.6e+00
—
—
2.7e+00
3.0e+00
cases:32.92%
controls:7.43%
cases:23.11%
controls:2.46%
cases:4.78%
controls:0.38%
—
—
—
—
cases:16.46%
controls:1.31%
cases:23.76%
controls:1.47%
79
168
161
2093
58
58
193
2303
12
9
239
2352
—
—
40
30
203
2252
48
28
154
1880
Gas panel - Venous blood
24339-4 [3000991]
1.3e+00
1.6e+00
2.5e+00
—
2.4e+00
2.1e+00
2.4e+00
cases:25.00%
controls:8.18%
cases:19.92%
controls:4.62%
cases:5.98%
controls:0.51%
—
—
cases:6.37%
controls:0.59%
cases:18.11%
controls:2.59%
cases:36.14%
controls:4.82%
60
185
180
2076
50
109
201
2252
15
12
236
2349
—
16
14
235
2340
44
59
199
2223
73
92
129
1816
Measurement of bone age from hand and elbow using X-ray
NK6MA [2001308495]
2.2e+00
2.9e+00
—
1.0e+50
—
3.6e+00
3.6e+00
cases:20.83%
controls:2.79%
cases:16.73%
controls:1.10%
—
—
cases:5.18%
controls:0.00%
—
—
cases:13.99%
controls:0.44%
cases:29.21%
controls:1.10%
50
63
190
2198
42
26
209
2335
—
13
0
238
2361
—
34
10
209
2272
59
21
143
1887
Pharmacy visit
OMOP4822462 [581458]
2.3e+00
1.9e+00
1.5e+00
1.5e+00
1.4e+00
1.5e+00
2.1e+00
cases:99.17%
controls:92.13%
cases:93.63%
controls:68.32%
cases:60.56%
controls:26.26%
cases:5.98%
controls:1.36%
cases:59.76%
controls:26.34%
cases:90.95%
controls:68.49%
cases:98.51%
controls:88.73%
238
2083
2
178
235
1613
16
748
152
620
99
1741
15
32
236
2329
150
620
101
1734
221
1563
22
719
199
1693
3
215
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
2.0e+00
2.5e+00
2.4e+00
1.0e+50
—
2.5e+00
2.9e+00
cases:15.00%
controls:2.39%
cases:13.55%
controls:1.23%
cases:2.39%
controls:0.21%
cases:1.99%
controls:0.00%
—
—
cases:13.99%
controls:1.36%
cases:31.68%
controls:2.52%
36
54
204
2207
34
29
217
2332
6
5
245
2356
5
0
246
2361
—
34
31
209
2251
64
48
138
1860
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
1.3e+00
1.8e+00
2.5e+00
1.0e+50
2.5e+00
2.2e+00
2.0e+00
cases:22.92%
controls:7.65%
cases:15.54%
controls:2.84%
cases:4.78%
controls:0.42%
cases:2.79%
controls:0.00%
cases:4.78%
controls:0.42%
cases:10.29%
controls:1.31%
cases:21.78%
controls:3.72%
55
173
185
2088
39
67
212
2294
12
10
239
2351
7
0
244
2361
12
10
239
2344
25
30
218
2252
44
71
158
1837
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
1.5e+00
1.8e+00
2.4e+00
—
2.2e+00
2.3e+00
2.0e+00
cases:23.75%
controls:6.77%
cases:17.93%
controls:3.47%
cases:6.77%
controls:0.68%
—
—
cases:5.98%
controls:0.68%
cases:19.75%
controls:2.50%
cases:31.68%
controls:5.71%
57
153
183
2108
45
82
206
2279
17
16
234
2345
—
15
16
236
2338
48
57
195
2225
64
109
138
1799
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
2.0e+00
2.5e+00
2.4e+00
1.0e+50
—
2.4e+00
2.8e+00
cases:15.42%
controls:2.39%
cases:13.94%
controls:1.36%
cases:2.39%
controls:0.21%
cases:1.99%
controls:0.00%
—
—
cases:13.99%
controls:1.40%
cases:30.69%
controls:2.73%
37
54
203
2207
35
32
216
2329
6
5
245
2356
5
0
246
2361
—
34
32
209
2250
62
52
140
1856
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.3e+00
1.8e+00
2.3e+00
—
2.2e+00
2.1e+00
2.3e+00
cases:25.42%
controls:8.54%
cases:22.71%
controls:4.45%
cases:7.57%
controls:0.85%
—
—
cases:6.77%
controls:0.76%
cases:20.99%
controls:3.20%
cases:36.63%
controls:5.66%
61
193
179
2068
57
105
194
2256
19
20
232
2341
—
17
18
234
2336
51
73
192
2209
74
108
128
1800
Immunohistochemistry procedure
117617002 [4035726]
2.2e+00
3.5e+00
—
—
—
2.9e+00
3.4e+00
cases:8.33%
controls:0.97%
cases:6.77%
controls:0.21%
—
—
—
—
—
—
cases:3.70%
controls:0.22%
cases:8.42%
controls:0.31%
20
22
220
2239
17
5
234
2356
—
—
—
9
5
234
2277
17
6
185
1902
Tooth plaque
K03.66 [2000502691]
2.3e+00
2.8e+00
—
1.0e+50
—
3.8e+00
3.0e+00
cases:18.75%
controls:2.26%
cases:12.35%
controls:0.89%
—
—
cases:15.14%
controls:0.00%
—
—
cases:17.28%
controls:0.48%
cases:44.55%
controls:3.72%
45
51
195
2210
31
21
220
2340
—
38
0
213
2361
—
42
11
201
2271
90
71
112
1837
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.9e+00
2.5e+00
2.4e+00
1.0e+50
—
2.4e+00
2.6e+00
cases:15.42%
controls:2.65%
cases:13.94%
controls:1.31%
cases:2.39%
controls:0.21%
cases:1.99%
controls:0.00%
—
—
cases:14.81%
controls:1.62%
cases:31.68%
controls:3.25%
37
60
203
2201
35
31
216
2330
6
5
245
2356
5
0
246
2361
—
36
37
207
2245
64
62
138
1846
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
1.8e+00
2.4e+00
2.7e+00
—
—
2.4e+00
2.5e+00
cases:16.25%
controls:3.23%
cases:12.75%
controls:1.27%
cases:3.19%
controls:0.21%
—
—
—
—
cases:9.88%
controls:1.01%
cases:18.81%
controls:1.94%
39
73
201
2188
32
30
219
2331
8
5
243
2356
—
—
24
23
219
2259
38
37
164
1871
Base excess in Venous blood by calculation
1927-3 [3002032]
1.3e+00
1.6e+00
2.5e+00
—
2.1e+00
2.0e+00
2.2e+00
cases:26.25%
controls:8.89%
cases:19.92%
controls:5.00%
cases:5.98%
controls:0.51%
—
—
cases:5.58%
controls:0.72%
cases:18.11%
controls:2.89%
cases:36.63%
controls:5.97%
63
201
177
2060
50
118
201
2243
15
12
236
2349
—
14
17
237
2337
44
66
199
2216
74
114
128
1794
Outpatient Hospital
22 [8756]
1.5e+00
1.9e+00
2.2e+00
1.0e+50
2.2e+00
2.0e+00
1.8e+00
cases:56.67%
controls:23.09%
cases:31.47%
controls:6.35%
cases:6.77%
controls:0.76%
cases:3.19%
controls:0.00%
cases:8.37%
controls:0.98%
cases:23.87%
controls:3.99%
cases:38.12%
controls:9.54%
136
522
104
1739
79
150
172
2211
17
18
234
2343
8
0
243
2361
21
23
230
2331
58
91
185
2191
77
182
125
1726
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.3e+00
1.6e+00
2.4e+00
—
2.0e+00
2.0e+00
2.3e+00
cases:25.83%
controls:8.36%
cases:19.52%
controls:4.70%
cases:5.58%
controls:0.51%
—
—
cases:4.78%
controls:0.68%
cases:16.05%
controls:2.63%
cases:35.64%
controls:5.35%
62
189
178
2072
49
111
202
2250
14
12
237
2349
—
12
16
239
2338
39
60
204
2222
72
102
130
1806
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
3193-0 [3005757]
2.0e+00
2.7e+00
—
—
—
3.1e+00
3.8e+00
cases:7.92%
controls:1.11%
cases:6.77%
controls:0.47%
—
—
—
—
—
—
cases:4.53%
controls:0.22%
cases:11.88%
controls:0.31%
19
25
221
2236
17
11
234
2350
—
—
—
11
5
232
2277
24
6
178
1902
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
1.5e+00
1.9e+00
2.4e+00
—
2.1e+00
1.8e+00
1.8e+00
cases:26.67%
controls:7.83%
cases:26.29%
controls:5.21%
cases:6.37%
controls:0.59%
—
—
cases:4.78%
controls:0.59%
cases:23.05%
controls:4.51%
cases:41.09%
controls:10.01%
64
177
176
2084
66
123
185
2238
16
14
235
2347
—
12
14
239
2340
56
103
187
2179
83
191
119
1717
pH of Venous blood
2746-6 [3012544]
1.3e+00
1.6e+00
2.4e+00
—
2.0e+00
2.0e+00
2.2e+00
cases:26.25%
controls:8.89%
cases:19.92%
controls:5.00%
cases:5.98%
controls:0.55%
—
—
cases:5.58%
controls:0.76%
cases:18.11%
controls:2.85%
cases:36.63%
controls:6.08%
63
201
177
2060
50
118
201
2243
15
13
236
2348
—
14
18
237
2336
44
65
199
2217
74
116
128
1792
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.3e+00
1.6e+00
2.4e+00
—
2.0e+00
2.0e+00
2.2e+00
cases:26.25%
controls:8.89%
cases:19.92%
controls:5.00%
cases:5.98%
controls:0.55%
—
—
cases:5.58%
controls:0.76%
cases:18.11%
controls:2.89%
cases:36.63%
controls:6.03%
63
201
177
2060
50
118
201
2243
15
13
236
2348
—
14
18
237
2336
44
66
199
2216
74
115
128
1793
INR in Blood by Coagulation assay
34714-6 [3032080]
1.1e+00
1.5e+00
2.7e+00
—
2.1e+00
1.7e+00
2.2e+00
cases:17.50%
controls:6.37%
cases:9.56%
controls:2.20%
cases:3.19%
controls:0.21%
—
—
cases:2.79%
controls:0.34%
cases:7.41%
controls:1.40%
cases:20.30%
controls:2.67%
42
144
198
2117
24
52
227
2309
8
5
243
2356
—
7
8
244
2346
18
32
225
2250
41
51
161
1857
Psychiatric consultation in another specialty
IAZ97 [2001304038]
2.2e+00
2.8e+00
—
1.0e+50
—
3.5e+00
2.9e+00
cases:6.25%
controls:0.71%
cases:6.77%
controls:0.42%
—
—
cases:2.39%
controls:0.00%
—
—
cases:6.58%
controls:0.22%
cases:14.36%
controls:0.94%
15
16
225
2245
17
10
234
2351
—
6
0
245
2361
—
16
5
227
2277
29
18
173
1890
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.3e+00
1.5e+00
2.3e+00
—
2.0e+00
2.0e+00
2.3e+00
cases:25.83%
controls:8.62%
cases:18.73%
controls:4.83%
cases:5.18%
controls:0.55%
—
—
cases:5.18%
controls:0.72%
cases:17.28%
controls:2.72%
cases:35.64%
controls:5.50%
62
195
178
2066
47
114
204
2247
13
13
238
2348
—
13
17
238
2337
42
62
201
2220
72
105
130
1803
One hour or less
ZXE00 [2001311394]
1.8e+00
2.1e+00
2.7e+00
—
—
2.7e+00
2.1e+00
cases:49.58%
controls:13.58%
cases:19.92%
controls:3.01%
cases:3.59%
controls:0.25%
—
—
—
—
cases:16.87%
controls:1.36%
cases:27.23%
controls:4.45%
119
307
121
1954
50
71
201
2290
9
6
242
2355
—
—
41
31
202
2251
55
85
147
1823
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
2.4e+00
3.0e+00
—
1.0e+50
—
2.9e+00
3.1e+00
cases:11.67%
controls:1.19%
cases:10.36%
controls:0.59%
—
—
cases:1.99%
controls:0.00%
—
—
cases:7.41%
controls:0.44%
cases:14.85%
controls:0.79%
28
27
212
2234
26
14
225
2347
—
5
0
246
2361
—
18
10
225
2272
30
15
172
1893
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
2.4e+00
3.0e+00
—
1.0e+50
—
2.9e+00
3.1e+00
cases:11.25%
controls:1.15%
cases:10.36%
controls:0.59%
—
—
cases:1.99%
controls:0.00%
—
—
cases:7.41%
controls:0.44%
cases:14.85%
controls:0.79%
27
26
213
2235
26
14
225
2347
—
5
0
246
2361
—
18
10
225
2272
30
15
172
1893
Intravenous
ZX120 [2001311495]
2.7e+00
2.8e+00
—
—
—
2.5e+00
3.2e+00
cases:17.50%
controls:1.37%
cases:7.97%
controls:0.51%
—
—
—
—
—
—
cases:4.12%
controls:0.35%
cases:11.39%
controls:0.52%
42
31
198
2230
20
12
231
2349
—
—
—
10
8
233
2274
23
10
179
1898
Psychologist
Z2445 [2001311558]
1.6e+00
1.9e+00
2.3e+00
—
2.1e+00
2.8e+00
2.8e+00
cases:17.50%
controls:3.98%
cases:7.57%
controls:1.23%
cases:1.99%
controls:0.21%
—
—
cases:2.79%
controls:0.34%
cases:7.82%
controls:0.53%
cases:12.87%
controls:0.89%
42
90
198
2171
19
29
232
2332
5
5
246
2356
—
7
8
244
2346
19
12
224
2270
26
17
176
1891
Intravenous general anesthesia
WX404 [2001310807]
2.0e+00
2.1e+00
2.2e+00
1.0e+50
—
2.5e+00
2.4e+00
cases:45.42%
controls:10.31%
cases:21.12%
controls:3.22%
cases:3.98%
controls:0.47%
cases:1.99%
controls:0.00%
—
—
cases:14.81%
controls:1.36%
cases:21.78%
controls:2.41%
109
233
131
2028
53
76
198
2285
10
11
241
2350
5
0
246
2361
—
36
31
207
2251
44
46
158
1862
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
2.4e+00
2.9e+00
—
1.0e+50
—
2.8e+00
3.1e+00
cases:11.25%
controls:1.15%
cases:10.36%
controls:0.64%
—
—
cases:1.99%
controls:0.00%
—
—
cases:7.41%
controls:0.48%
cases:14.85%
controls:0.79%
27
26
213
2235
26
15
225
2346
—
5
0
246
2361
—
18
11
225
2271
30
15
172
1893
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.1e+00
2.9e+00
—
1.0e+50
—
2.8e+00
3.3e+00
cases:14.58%
controls:2.12%
cases:13.15%
controls:0.85%
—
—
cases:3.98%
controls:0.00%
—
—
cases:10.70%
controls:0.70%
cases:26.24%
controls:1.31%
35
48
205
2213
33
20
218
2341
—
10
0
241
2361
—
26
16
217
2266
53
25
149
1883
Protein [Mass/volume] in Urine
2888-6 [3037121]
1.7e+00
2.1e+00
1.7e+00
—
3.0e+00
1.8e+00
2.5e+00
cases:11.25%
controls:2.26%
cases:10.36%
controls:1.36%
cases:1.99%
controls:0.38%
—
—
cases:3.98%
controls:0.21%
cases:8.23%
controls:1.53%
cases:19.80%
controls:2.04%
27
51
213
2210
26
32
225
2329
5
9
246
2352
—
10
5
241
2349
20
35
223
2247
40
39
162
1869
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.0e+00
1.6e+00
2.4e+00
1.0e+50
2.5e+00
1.7e+00
1.7e+00
cases:23.33%
controls:9.64%
cases:15.94%
controls:3.52%
cases:4.78%
controls:0.47%
cases:1.99%
controls:0.00%
cases:4.78%
controls:0.42%
cases:10.29%
controls:2.02%
cases:22.77%
controls:5.19%
56
218
184
2043
40
83
211
2278
12
11
239
2350
5
0
246
2361
12
10
239
2344
25
46
218
2236
46
99
156
1809
General Practice Dentistry
1223G0001X [38003675]
2.5e+00
2.8e+00
—
1.0e+50
—
2.8e+00
2.8e+00
cases:14.58%
controls:1.33%
cases:11.55%
controls:0.80%
—
—
cases:11.55%
controls:0.00%
—
—
cases:14.81%
controls:1.10%
cases:38.61%
controls:3.56%
35
30
205
2231
29
19
222
2342
—
29
0
222
2361
—
36
25
207
2257
78
68
124
1840
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 [21492711]
3.0e+00
2.3e+00
—
—
—
3.1e+00
2.6e+00
cases:5.00%
controls:0.27%
cases:3.19%
controls:0.34%
—
—
—
—
—
—
cases:4.53%
controls:0.22%
cases:6.93%
controls:0.58%
12
6
228
2255
8
8
243
2353
—
—
—
11
5
232
2277
14
11
188
1897
Other healthcare associate professional
Z3229 [2001311561]
2.0e+00
2.5e+00
—
—
—
3.3e+00
3.0e+00
cases:18.33%
controls:2.87%
cases:11.16%
controls:1.02%
—
—
—
—
—
—
cases:10.29%
controls:0.44%
cases:17.82%
controls:1.05%
44
65
196
2196
28
24
223
2337
—
—
—
25
10
218
2272
36
20
166
1888
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
1.2e+00
1.7e+00
2.2e+00
—
2.2e+00
1.8e+00
1.8e+00
cases:32.08%
controls:13.00%
cases:28.29%
controls:6.73%
cases:9.16%
controls:1.14%
—
—
cases:8.76%
controls:1.10%
cases:26.75%
controls:5.70%
cases:46.53%
controls:12.16%
77
294
163
1967
71
159
180
2202
23
27
228
2334
—
22
26
229
2328
65
130
178
2152
94
232
108
1676
Insulin [Units/volume] in Serum or Plasma
20448-7 [3016244]
1.9e+00
2.7e+00
—
—
—
3.0e+00
3.2e+00
cases:5.00%
controls:0.80%
cases:7.57%
controls:0.55%
—
—
—
—
—
—
cases:6.58%
controls:0.35%
cases:19.31%
controls:0.94%
12
18
228
2243
19
13
232
2348
—
—
—
16
8
227
2274
39
18
163
1890
Thorax X-ray examination
GD1AA [2001303617]
1.6e+00
2.0e+00
2.2e+00
1.0e+50
1.9e+00
2.5e+00
2.5e+00
cases:30.83%
controls:8.01%
cases:17.53%
controls:2.92%
cases:3.19%
controls:0.38%
cases:2.39%
controls:0.00%
cases:1.99%
controls:0.30%
cases:15.23%
controls:1.45%
cases:32.18%
controls:3.62%
74
181
166
2080
44
69
207
2292
8
9
243
2352
6
0
245
2361
5
7
246
2347
37
33
206
2249
65
69
137
1839
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
1.9e+00
2.9e+00
—
—
—
2.9e+00
3.1e+00
cases:5.42%
controls:0.88%
cases:5.58%
controls:0.34%
—
—
—
—
—
—
cases:4.53%
controls:0.26%
cases:9.90%
controls:0.47%
13
20
227
2241
14
8
237
2353
—
—
—
11
6
232
2276
20
9
182
1899
acetylsalicylic acid; oral
B01AC06 [21600991]
1.8e+00
2.9e+00
—
—
—
2.9e+00
3.1e+00
cases:5.42%
controls:0.93%
cases:5.58%
controls:0.34%
—
—
—
—
—
—
cases:4.53%
controls:0.26%
cases:9.90%
controls:0.47%
13
21
227
2240
14
8
237
2353
—
—
—
11
6
232
2276
20
9
182
1899
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
1.1e+00
1.9e+00
1.7e+00
—
2.3e+00
1.8e+00
1.9e+00
cases:23.75%
controls:9.69%
cases:20.72%
controls:3.90%
cases:4.38%
controls:0.85%
—
—
cases:5.98%
controls:0.64%
cases:17.28%
controls:3.37%
cases:33.17%
controls:6.76%
57
219
183
2042
52
92
199
2269
11
20
240
2341
—
15
15
236
2339
42
77
201
2205
67
129
135
1779
Pediatric Medicine
37 [38004477]
1.4e+00
1.8e+00
1.6e+00
—
2.1e+00
1.9e+00
1.8e+00
cases:78.33%
controls:46.88%
cases:67.33%
controls:26.34%
cases:22.31%
controls:5.51%
—
—
cases:29.08%
controls:4.72%
cases:63.79%
controls:21.21%
cases:73.76%
controls:30.77%
188
1060
52
1201
169
622
82
1739
56
130
195
2231
—
73
111
178
2243
155
484
88
1798
149
587
53
1321
Bacteria [Presence] in Urine
87829-8 [36304419]
1.1e+00
1.9e+00
1.6e+00
—
2.3e+00
1.9e+00
1.9e+00
cases:23.75%
controls:9.73%
cases:20.72%
controls:3.85%
cases:3.98%
controls:0.85%
—
—
cases:5.98%
controls:0.64%
cases:17.70%
controls:3.24%
cases:33.17%
controls:6.87%
57
220
183
2041
52
91
199
2270
10
20
241
2341
—
15
15
236
2339
43
74
200
2208
67
131
135
1777
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1.0e+00
1.6e+00
2.2e+00
—
2.0e+00
1.8e+00
1.8e+00
cases:34.58%
controls:15.70%
cases:29.48%
controls:7.92%
cases:11.16%
controls:1.31%
—
—
cases:7.97%
controls:1.19%
cases:26.75%
controls:5.43%
cases:43.07%
controls:10.74%
83
355
157
1906
74
187
177
2174
28
31
223
2330
—
20
28
231
2326
65
124
178
2158
87
205
115
1703
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.0e+00
1.6e+00
2.1e+00
—
2.1e+00
1.9e+00
1.9e+00
cases:34.58%
controls:15.88%
cases:29.48%
controls:7.96%
cases:10.76%
controls:1.40%
—
—
cases:9.16%
controls:1.27%
cases:27.16%
controls:5.52%
cases:44.06%
controls:10.95%
83
359
157
1902
74
188
177
2173
27
33
224
2328
—
23
30
228
2324
66
126
177
2156
89
209
113
1699
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.9e-01
8.1e-01
1.6e+00
3.8e+00
1.9e+00
1.2e+00
1.2e+00
cases:45.00%
controls:35.69%
cases:42.63%
controls:24.90%
cases:21.12%
controls:4.91%
cases:8.37%
controls:0.21%
cases:19.12%
controls:3.57%
cases:44.03%
controls:19.85%
cases:63.86%
controls:34.12%
108
807
132
1454
107
588
144
1773
53
116
198
2245
21
5
230
2356
48
84
203
2270
107
453
136
1829
129
651
73
1257
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
1.0e+00
1.7e+00
1.7e+00
—
2.3e+00
1.8e+00
1.9e+00
cases:25.42%
controls:10.75%
cases:20.32%
controls:4.45%
cases:4.78%
controls:0.93%
—
—
cases:6.37%
controls:0.68%
cases:19.75%
controls:3.81%
cases:34.65%
controls:7.60%
61
243
179
2018
51
105
200
2256
12
22
239
2339
—
16
16
235
2338
48
87
195
2195
70
145
132
1763
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.5e+00
1.7e+00
2.7e+00
—
2.3e+00
2.2e+00
2.2e+00
cases:13.75%
controls:3.32%
cases:9.96%
controls:1.95%
cases:4.38%
controls:0.30%
—
—
cases:1.99%
controls:0.21%
cases:7.82%
controls:0.96%
cases:15.35%
controls:1.94%
33
75
207
2186
25
46
226
2315
11
7
240
2354
—
5
5
246
2349
19
22
224
2260
31
37
171
1871
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
1.0e+00
1.8e+00
1.7e+00
—
2.2e+00
1.8e+00
1.8e+00
cases:24.58%
controls:10.31%
cases:20.72%
controls:4.15%
cases:4.38%
controls:0.85%
—
—
cases:5.98%
controls:0.68%
cases:17.70%
controls:3.59%
cases:33.66%
controls:7.76%
59
233
181
2028
52
98
199
2263
11
20
240
2341
—
15
16
236
2338
43
82
200
2200
68
148
134
1760
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
2.2e+00
2.8e+00
—
—
—
2.7e+00
2.5e+00
cases:12.08%
controls:1.55%
cases:9.96%
controls:0.64%
—
—
—
—
—
—
cases:8.23%
controls:0.61%
cases:11.88%
controls:1.10%
29
35
211
2226
25
15
226
2346
—
—
—
20
14
223
2268
24
21
178
1887
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
2.2e+00
2.8e+00
—
—
—
2.7e+00
2.5e+00
cases:12.08%
controls:1.55%
cases:9.96%
controls:0.64%
—
—
—
—
—
—
cases:8.23%
controls:0.61%
cases:11.88%
controls:1.10%
29
35
211
2226
25
15
226
2346
—
—
—
20
14
223
2268
24
21
178
1887
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
2.2e+00
2.9e+00
—
—
—
2.6e+00
2.4e+00
cases:7.92%
controls:0.93%
cases:4.38%
controls:0.25%
—
—
—
—
—
—
cases:2.88%
controls:0.22%
cases:3.47%
controls:0.31%
19
21
221
2240
11
6
240
2355
—
—
—
7
5
236
2277
7
6
195
1902
furosemide; oral, parenteral
C03CA01 [21601518]
2.6e+00
2.6e+00
—
—
—
2.3e+00
2.6e+00
cases:12.08%
controls:0.97%
cases:5.18%
controls:0.42%
—
—
—
—
—
—
cases:4.12%
controls:0.44%
cases:5.94%
controls:0.47%
29
22
211
2239
13
10
238
2351
—
—
—
10
10
233
2272
12
9
190
1899
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
1.2e+00
1.7e+00
1.8e+00
—
2.3e+00
1.4e+00
1.6e+00
cases:19.17%
controls:6.77%
cases:17.93%
controls:3.85%
cases:3.19%
controls:0.55%
—
—
cases:3.98%
controls:0.42%
cases:14.81%
controls:3.99%
cases:27.72%
controls:7.44%
46
153
194
2108
45
91
206
2270
8
13
243
2348
—
10
10
241
2344
36
91
207
2191
56
142
146
1766
Leukocytes [#/volume] in Urine
30405-5 [3018095]
1.0e+00
1.7e+00
1.8e+00
—
2.2e+00
1.7e+00
1.5e+00
cases:25.83%
controls:11.10%
cases:21.12%
controls:4.87%
cases:4.78%
controls:0.85%
—
—
cases:6.37%
controls:0.76%
cases:20.16%
controls:4.38%
cases:35.15%
controls:10.38%
62
251
178
2010
53
115
198
2246
12
20
239
2341
—
16
18
235
2336
49
100
194
2182
71
198
131
1710
Parainfluenza type 1 nucleic acid detection
222341000000100 [44790047]
2.0e+00
2.7e+00
—
—
—
2.6e+00
2.6e+00
cases:6.25%
controls:0.93%
cases:4.78%
controls:0.34%
—
—
—
—
—
—
cases:3.29%
controls:0.26%
cases:4.95%
controls:0.37%
15
21
225
2240
12
8
239
2353
—
—
—
8
6
235
2276
10
7
192
1901
Parainfluenza type 2 nucleic acid detection
222351000000102 [44790048]
2.0e+00
2.7e+00
—
—
—
2.6e+00
2.6e+00
cases:6.25%
controls:0.93%
cases:4.78%
controls:0.34%
—
—
—
—
—
—
cases:3.29%
controls:0.26%
cases:4.95%
controls:0.37%
15
21
225
2240
12
8
239
2353
—
—
—
8
6
235
2276
10
7
192
1901
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
2.0e+00
2.7e+00
—
—
—
2.6e+00
2.6e+00
cases:6.25%
controls:0.93%
cases:4.78%
controls:0.34%
—
—
—
—
—
—
cases:3.29%
controls:0.26%
cases:4.95%
controls:0.37%
15
21
225
2240
12
8
239
2353
—
—
—
8
6
235
2276
10
7
192
1901
Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]
2.0e+00
2.7e+00
—
—
—
2.6e+00
2.6e+00
cases:6.25%
controls:0.93%
cases:4.78%
controls:0.34%
—
—
—
—
—
—
cases:3.29%
controls:0.26%
cases:4.95%
controls:0.37%
15
21
225
2240
12
8
239
2353
—
—
—
8
6
235
2276
10
7
192
1901
ECG with 12 standard connections
XF400 [2001303368]
1.6e+00
1.9e+00
2.1e+00
1.0e+50
—
2.0e+00
2.2e+00
cases:26.67%
controls:7.03%
cases:13.15%
controls:2.24%
cases:2.79%
controls:0.34%
cases:3.19%
controls:0.00%
—
—
cases:9.47%
controls:1.40%
cases:18.81%
controls:2.46%
64
159
176
2102
33
53
218
2308
7
8
244
2353
8
0
243
2361
—
23
32
220
2250
38
47
164
1861
enalapril; oral, parenteral
C09AA02 [21601786]
2.4e+00
2.7e+00
—
—
—
2.4e+00
2.3e+00
cases:9.17%
controls:0.88%
cases:7.97%
controls:0.59%
—
—
—
—
—
—
cases:6.58%
controls:0.66%
cases:8.91%
controls:0.94%
22
20
218
2241
20
14
231
2347
—
—
—
16
15
227
2267
18
18
184
1890
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
1.9e+00
2.9e+00
—
—
—
2.5e+00
2.5e+00
cases:7.50%
controls:1.15%
cases:5.58%
controls:0.34%
—
—
—
—
—
—
cases:3.70%
controls:0.31%
cases:6.44%
controls:0.58%
18
26
222
2235
14
8
237
2353
—
—
—
9
7
234
2275
13
11
189
1897
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
2.0e+00
2.9e+00
—
—
—
2.5e+00
2.4e+00
cases:7.92%
controls:1.15%
cases:5.58%
controls:0.34%
—
—
—
—
—
—
cases:3.70%
controls:0.31%
cases:6.93%
controls:0.68%
19
26
221
2235
14
8
237
2353
—
—
—
9
7
234
2275
14
13
188
1895
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
9.7e-01
1.4e+00
1.7e+00
—
1.8e+00
1.8e+00
2.0e+00
cases:22.92%
controls:10.13%
cases:19.12%
controls:5.59%
cases:5.58%
controls:1.02%
—
—
cases:5.58%
controls:0.93%
cases:18.11%
controls:3.51%
cases:33.17%
controls:6.39%
55
229
185
2032
48
132
203
2229
14
24
237
2337
—
14
22
237
2332
44
80
199
2202
67
122
135
1786
Short blood count panel - Blood
55429-5 [40758558]
9.6e-01
1.0e+00
1.8e+00
1.0e+50
2.2e+00
1.4e+00
2.3e+00
cases:28.33%
controls:13.09%
cases:17.13%
controls:6.78%
cases:7.57%
controls:1.40%
cases:4.78%
controls:0.00%
cases:8.76%
controls:1.02%
cases:15.23%
controls:4.16%
cases:38.12%
controls:5.97%
68
296
172
1965
43
160
208
2201
19
33
232
2328
12
0
239
2361
22
24
229
2330
37
95
206
2187
77
114
125
1794
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.2e-01
6.6e-01
1.6e+00
3.8e+00
1.7e+00
9.7e-01
9.3e-01
cases:47.08%
controls:41.66%
cases:45.02%
controls:29.73%
cases:23.11%
controls:5.80%
cases:8.76%
controls:0.21%
cases:21.51%
controls:4.67%
cases:46.91%
controls:25.02%
cases:67.82%
controls:45.49%
113
942
127
1319
113
702
138
1659
58
137
193
2224
22
5
229
2356
54
110
197
2244
114
571
129
1711
137
868
65
1040
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.2e-01
6.6e-01
1.6e+00
3.8e+00
1.7e+00
9.8e-01
9.3e-01
cases:47.08%
controls:41.66%
cases:45.02%
controls:29.69%
cases:23.11%
controls:5.80%
cases:8.37%
controls:0.21%
cases:21.51%
controls:4.67%
cases:46.91%
controls:24.98%
cases:67.82%
controls:45.49%
113
942
127
1319
113
701
138
1660
58
137
193
2224
21
5
230
2356
54
110
197
2244
114
570
129
1712
137
868
65
1040
MCH [Entitic mass]
28539-5 [3035941]
2.2e-01
6.6e-01
1.6e+00
3.8e+00
1.7e+00
9.7e-01
9.3e-01
cases:47.08%
controls:41.66%
cases:45.02%
controls:29.69%
cases:23.11%
controls:5.80%
cases:8.37%
controls:0.21%
cases:21.51%
controls:4.67%
cases:46.91%
controls:25.02%
cases:67.82%
controls:45.49%
113
942
127
1319
113
701
138
1660
58
137
193
2224
21
5
230
2356
54
110
197
2244
114
571
129
1711
137
868
65
1040
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.2e-01
6.6e-01
1.6e+00
3.8e+00
1.7e+00
9.7e-01
9.3e-01
cases:47.08%
controls:41.66%
cases:45.02%
controls:29.73%
cases:23.11%
controls:5.80%
cases:8.37%
controls:0.21%
cases:21.51%
controls:4.67%
cases:46.91%
controls:25.02%
cases:67.82%
controls:45.49%
113
942
127
1319
113
702
138
1659
58
137
193
2224
21
5
230
2356
54
110
197
2244
114
571
129
1711
137
868
65
1040
Platelets [#/volume] in Blood
26515-7 [3007461]
2.2e-01
6.6e-01
1.6e+00
3.8e+00
1.7e+00
9.7e-01
9.3e-01
cases:47.08%
controls:41.57%
cases:45.02%
controls:29.73%
cases:23.11%
controls:5.84%
cases:8.37%
controls:0.21%
cases:21.51%
controls:4.67%
cases:46.91%
controls:25.02%
cases:67.82%
controls:45.44%
113
940
127
1321
113
702
138
1659
58
138
193
2223
21
5
230
2356
54
110
197
2244
114
571
129
1711
137
867
65
1041
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.2e-01
6.6e-01
1.6e+00
3.8e+00
1.7e+00
9.7e-01
9.2e-01
cases:47.08%
controls:41.66%
cases:45.02%
controls:29.78%
cases:23.11%
controls:5.84%
cases:8.37%
controls:0.21%
cases:21.51%
controls:4.67%
cases:46.91%
controls:25.07%
cases:67.82%
controls:45.60%
113
942
127
1319
113
703
138
1658
58
138
193
2223
21
5
230
2356
54
110
197
2244
114
572
129
1710
137
870
65
1038
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.1e-01
8.1e-01
1.6e+00
3.5e+00
1.6e+00
1.0e+00
1.1e+00
cases:40.42%
controls:33.22%
cases:31.87%
controls:17.24%
cases:14.34%
controls:3.22%
cases:6.37%
controls:0.21%
cases:14.34%
controls:3.31%
cases:34.98%
controls:16.17%
cases:58.91%
controls:32.39%
97
751
143
1510
80
407
171
1954
36
76
215
2285
16
5
235
2356
36
78
215
2276
85
369
158
1913
119
618
83
1290
Osmolality of Urine
2695-5 [3026782]
1.1e+00
1.7e+00
—
—
2.5e+00
2.0e+00
2.3e+00
cases:18.33%
controls:7.03%
cases:11.16%
controls:2.24%
—
—
—
—
cases:3.59%
controls:0.30%
cases:7.82%
controls:1.14%
cases:21.29%
controls:2.67%
44
159
196
2102
28
53
223
2308
—
—
9
7
242
2347
19
26
224
2256
43
51
159
1857
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.2e-01
6.5e-01
1.6e+00
3.8e+00
1.7e+00
9.7e-01
9.0e-01
cases:47.08%
controls:41.75%
cases:45.02%
controls:29.94%
cases:23.11%
controls:5.80%
cases:8.37%
controls:0.21%
cases:21.51%
controls:4.72%
cases:46.91%
controls:25.15%
cases:67.82%
controls:46.23%
113
944
127
1317
113
707
138
1654
58
137
193
2224
21
5
230
2356
54
111
197
2243
114
574
129
1708
137
882
65
1026
Postnatal enamel hypoplasia
K00.40 [2000502632]
-1.0e+50
-1.0e+50
—
1.0e+50
1.0e+50
5.3e+00
4.3e+00
cases:0.00%
controls:0.57%
cases:0.00%
controls:0.34%
—
—
cases:75.70%
controls:0.00%
cases:20.72%
controls:0.00%
cases:33.74%
controls:0.26%
cases:52.48%
controls:1.47%
0
13
240
2248
0
8
251
2353
—
190
0
61
2361
52
0
199
2354
82
6
161
2276
106
28
96
1880
Differential panel, method unspecified - Blood
69738-3 [42870588]
1.0e+00
1.4e+00
1.8e+00
—
2.0e+00
1.7e+00
1.7e+00
cases:30.00%
controls:13.27%
cases:27.09%
controls:8.73%
cases:11.16%
controls:2.08%
—
—
cases:11.16%
controls:1.70%
cases:29.63%
controls:7.19%
cases:46.53%
controls:13.47%
72
300
168
1961
68
206
183
2155
28
49
223
2312
—
28
40
223
2314
72
164
171
2118
94
257
108
1651
hydrocortisone; oral, parenteral
H02AB09 [21602737]
2.5e+00
2.5e+00
—
—
—
2.4e+00
2.2e+00
cases:23.75%
controls:2.57%
cases:11.16%
controls:0.97%
—
—
—
—
—
—
cases:10.29%
controls:1.05%
cases:17.33%
controls:2.36%
57
58
183
2203
28
23
223
2338
—
—
—
25
24
218
2258
35
45
167
1863
Monocytes/Leukocytes in Blood
26485-3 [3019069]
8.4e-01
1.3e+00
1.9e+00
—
2.0e+00
1.7e+00
1.7e+00
cases:33.75%
controls:18.05%
cases:30.28%
controls:10.84%
cases:13.55%
controls:2.33%
—
—
cases:12.75%
controls:1.95%
cases:33.33%
controls:8.02%
cases:51.98%
controls:16.09%
81
408
159
1853
76
256
175
2105
34
55
217
2306
—
32
46
219
2308
81
183
162
2099
105
307
97
1601
Inpatient Hospital
21 [8717]
1.5e+00
1.7e+00
1.7e+00
—
1.5e+00
1.6e+00
1.5e+00
cases:64.17%
controls:28.26%
cases:33.47%
controls:8.56%
cases:6.37%
controls:1.27%
—
—
cases:5.98%
controls:1.36%
cases:23.46%
controls:5.96%
cases:39.11%
controls:12.74%
154
639
86
1622
84
202
167
2159
16
30
235
2331
—
15
32
236
2322
57
136
186
2146
79
243
123
1665
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
8.4e-01
1.3e+00
1.8e+00
—
2.0e+00
1.8e+00
1.7e+00
cases:33.75%
controls:18.00%
cases:30.28%
controls:10.84%
cases:13.15%
controls:2.33%
—
—
cases:12.75%
controls:1.95%
cases:33.33%
controls:7.98%
cases:51.98%
controls:16.09%
81
407
159
1854
76
256
175
2105
33
55
218
2306
—
32
46
219
2308
81
182
162
2100
105
307
97
1601
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
7.0e-01
1.3e+00
2.0e+00
1.0e+50
2.0e+00
1.8e+00
1.6e+00
cases:21.67%
controls:12.07%
cases:16.73%
controls:5.04%
cases:3.19%
controls:0.42%
cases:3.19%
controls:0.00%
cases:4.78%
controls:0.68%
cases:17.70%
controls:3.55%
cases:37.62%
controls:10.95%
52
273
188
1988
42
119
209
2242
8
10
243
2351
8
0
243
2361
12
16
239
2338
43
81
200
2201
76
209
126
1699
Basophils [#/volume] in Blood
26444-0 [3006315]
8.6e-01
1.3e+00
1.8e+00
—
1.9e+00
1.8e+00
1.7e+00
cases:34.58%
controls:18.35%
cases:30.68%
controls:11.10%
cases:13.55%
controls:2.41%
—
—
cases:11.95%
controls:1.91%
cases:34.57%
controls:8.33%
cases:53.96%
controls:16.93%
83
415
157
1846
77
262
174
2099
34
57
217
2304
—
30
45
221
2309
84
190
159
2092
109
323
93
1585
Basophils/Leukocytes in Blood
30180-4 [3022096]
8.4e-01
1.3e+00
1.9e+00
—
1.9e+00
1.8e+00
1.7e+00
cases:33.75%
controls:18.05%
cases:30.28%
controls:10.84%
cases:13.55%
controls:2.33%
—
—
cases:11.95%
controls:1.95%
cases:33.33%
controls:7.93%
cases:51.98%
controls:15.93%
81
408
159
1853
76
256
175
2105
34
55
217
2306
—
30
46
221
2308
81
181
162
2101
105
304
97
1604
Monocytes [#/volume] in Blood
26484-6 [3001604]
8.6e-01
1.3e+00
1.8e+00
—
1.9e+00
1.8e+00
1.7e+00
cases:34.58%
controls:18.35%
cases:30.68%
controls:11.10%
cases:13.55%
controls:2.41%
—
—
cases:11.95%
controls:1.91%
cases:34.57%
controls:8.37%
cases:53.96%
controls:16.98%
83
415
157
1846
77
262
174
2099
34
57
217
2304
—
30
45
221
2309
84
191
159
2091
109
324
93
1584
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1.3e+00
1.7e+00
1.5e+00
1.0e+50
2.4e+00
1.9e+00
2.0e+00
cases:20.00%
controls:6.37%
cases:14.34%
controls:2.84%
cases:2.39%
controls:0.55%
cases:2.79%
controls:0.00%
cases:3.19%
controls:0.30%
cases:12.35%
controls:2.02%
cases:28.22%
controls:4.98%
48
144
192
2117
36
67
215
2294
6
13
245
2348
7
0
244
2361
8
7
243
2347
30
46
213
2236
57
95
145
1813
Oxygen saturation in Venous blood
2711-0 [3024928]
2.0e+00
2.5e+00
—
—
—
2.7e+00
2.2e+00
cases:3.33%
controls:0.49%
cases:3.98%
controls:0.34%
—
—
—
—
—
—
cases:3.29%
controls:0.22%
cases:4.46%
controls:0.52%
8
11
232
2250
10
8
241
2353
—
—
—
8
5
235
2277
9
10
193
1898
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
8.2e-01
1.2e+00
1.9e+00
—
1.9e+00
1.7e+00
1.7e+00
cases:33.75%
controls:18.27%
cases:30.28%
controls:11.22%
cases:13.55%
controls:2.24%
—
—
cases:12.35%
controls:2.04%
cases:33.33%
controls:8.11%
cases:51.49%
controls:15.67%
81
413
159
1848
76
265
175
2096
34
53
217
2308
—
31
48
220
2306
81
185
162
2097
104
299
98
1609
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
1.9e+00
2.4e+00
—
—
—
2.3e+00
2.8e+00
cases:13.75%
controls:2.39%
cases:9.56%
controls:0.97%
—
—
—
—
—
—
cases:6.58%
controls:0.70%
cases:14.36%
controls:1.00%
33
54
207
2207
24
23
227
2338
—
—
—
16
16
227
2266
29
19
173
1889
Pediatric Surgery
OMOP4822020 [45756819]
1.2e+00
1.5e+00
1.4e+00
—
2.0e+00
1.6e+00
1.8e+00
cases:42.92%
controls:19.20%
cases:26.29%
controls:7.71%
cases:5.18%
controls:1.31%
—
—
cases:7.57%
controls:1.10%
cases:25.51%
controls:6.62%
cases:50.00%
controls:14.52%
103
434
137
1827
66
182
185
2179
13
31
238
2330
—
19
26
232
2328
62
151
181
2131
101
277
101
1631
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
7.4e-01
1.4e+00
2.1e+00
1.0e+50
2.1e+00
1.6e+00
1.4e+00
cases:23.33%
controls:12.69%
cases:20.72%
controls:6.18%
cases:4.78%
controls:0.59%
cases:3.59%
controls:0.00%
cases:5.18%
controls:0.64%
cases:20.99%
controls:5.26%
cases:40.59%
controls:14.47%
56
287
184
1974
52
146
199
2215
12
14
239
2347
9
0
242
2361
13
15
238
2339
51
120
192
2162
82
276
120
1632
Eosinophils [#/volume] in Blood
26449-9 [3013115]
8.5e-01
1.2e+00
1.8e+00
—
2.0e+00
1.7e+00
1.7e+00
cases:35.00%
controls:18.75%
cases:30.68%
controls:11.69%
cases:13.94%
controls:2.50%
—
—
cases:13.55%
controls:2.00%
cases:34.57%
controls:8.81%
cases:53.96%
controls:17.77%
84
424
156
1837
77
276
174
2085
35
59
216
2302
—
34
47
217
2307
84
201
159
2081
109
339
93
1569
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
1.9e+00
2.3e+00
—
—
—
2.3e+00
2.9e+00
cases:13.75%
controls:2.43%
cases:9.56%
controls:1.06%
—
—
—
—
—
—
cases:6.58%
controls:0.70%
cases:13.86%
controls:0.89%
33
55
207
2206
24
25
227
2336
—
—
—
16
16
227
2266
28
17
174
1891
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
1.5e+00
2.1e+00
—
—
—
2.5e+00
3.2e+00
cases:5.00%
controls:1.11%
cases:5.58%
controls:0.72%
—
—
—
—
—
—
cases:4.94%
controls:0.44%
cases:10.40%
controls:0.47%
12
25
228
2236
14
17
237
2344
—
—
—
12
10
231
2272
21
9
181
1899
Social worker
Z2446 [2001311559]
1.7e+00
2.2e+00
2.3e+00
—
—
2.6e+00
2.8e+00
cases:24.58%
controls:5.57%
cases:12.75%
controls:1.65%
cases:1.99%
controls:0.21%
—
—
—
—
cases:7.41%
controls:0.57%
cases:12.87%
controls:0.89%
59
126
181
2135
32
39
219
2322
5
5
246
2356
—
—
18
13
225
2269
26
17
176
1891
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
7.3e-01
1.5e+00
2.0e+00
1.0e+50
2.1e+00
1.6e+00
1.4e+00
cases:22.50%
controls:12.30%
cases:21.12%
controls:5.84%
cases:4.38%
controls:0.59%
cases:3.59%
controls:0.00%
cases:4.78%
controls:0.64%
cases:20.58%
controls:5.04%
cases:40.10%
controls:13.94%
54
278
186
1983
53
138
198
2223
11
14
240
2347
9
0
242
2361
12
15
239
2339
50
115
193
2167
81
266
121
1642
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
8.1e-01
1.2e+00
1.9e+00
—
2.0e+00
1.7e+00
1.7e+00
cases:35.42%
controls:19.55%
cases:30.28%
controls:11.94%
cases:14.34%
controls:2.54%
—
—
cases:14.34%
controls:2.12%
cases:35.39%
controls:8.90%
cases:53.47%
controls:17.71%
85
442
155
1819
76
282
175
2079
36
60
215
2301
—
36
50
215
2304
86
203
157
2079
108
338
94
1570
Thrombin time
3243-3 [3036489]
1.9e+00
2.3e+00
—
—
—
2.3e+00
2.8e+00
cases:14.17%
controls:2.43%
cases:9.56%
controls:1.06%
—
—
—
—
—
—
cases:6.58%
controls:0.70%
cases:14.85%
controls:1.05%
34
55
206
2206
24
25
227
2336
—
—
—
16
16
227
2266
30
20
172
1888
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
8.3e-01
1.2e+00
1.9e+00
—
1.8e+00
1.7e+00
1.8e+00
cases:34.58%
controls:18.80%
cases:30.28%
controls:11.39%
cases:13.15%
controls:2.29%
—
—
cases:11.55%
controls:2.08%
cases:34.16%
controls:8.55%
cases:54.46%
controls:17.09%
83
425
157
1836
76
269
175
2092
33
54
218
2307
—
29
49
222
2305
83
195
160
2087
110
326
92
1582
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
1.4e+00
1.7e+00
1.4e+00
—
1.4e+00
1.7e+00
1.6e+00
cases:25.83%
controls:8.14%
cases:23.51%
controls:5.21%
cases:7.57%
controls:1.99%
—
—
cases:9.56%
controls:2.51%
cases:21.40%
controls:4.73%
cases:38.12%
controls:11.11%
62
184
178
2077
59
123
192
2238
19
47
232
2314
—
24
59
227
2295
52
108
191
2174
77
212
125
1696
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
8.8e-01
1.4e+00
1.9e+00
—
2.1e+00
1.4e+00
1.6e+00
cases:30.42%
controls:15.39%
cases:22.71%
controls:6.99%
cases:5.18%
controls:0.80%
—
—
cases:5.98%
controls:0.81%
cases:18.52%
controls:5.26%
cases:39.11%
controls:11.69%
73
348
167
1913
57
165
194
2196
13
19
238
2342
—
15
19
236
2335
45
120
198
2162
79
223
123
1685
Normoblasts [#/volume] in Blood
715-3 [3021589]
8.4e-01
1.2e+00
1.7e+00
—
1.9e+00
1.7e+00
1.8e+00
cases:32.92%
controls:17.43%
cases:29.88%
controls:10.93%
cases:12.75%
controls:2.58%
—
—
cases:12.35%
controls:2.08%
cases:31.69%
controls:8.02%
cases:50.99%
controls:14.31%
79
394
161
1867
75
258
176
2103
32
61
219
2300
—
31
49
220
2305
77
183
166
2099
103
273
99
1635
Nephrology
39 [38004479]
3.1e+00
2.9e+00
—
—
—
—
3.2e+00
cases:4.58%
controls:0.22%
cases:4.38%
controls:0.25%
—
—
—
—
—
—
—
—
cases:5.94%
controls:0.26%
11
5
229
2256
11
6
240
2355
—
—
—
—
12
5
190
1903
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
7.8e-01
1.2e+00
1.9e+00
—
1.9e+00
1.7e+00
1.7e+00
cases:33.75%
controls:18.97%
cases:30.28%
controls:11.44%
cases:13.55%
controls:2.37%
—
—
cases:12.75%
controls:2.17%
cases:33.33%
controls:8.63%
cases:52.48%
controls:16.67%
81
429
159
1832
76
270
175
2091
34
56
217
2305
—
32
51
219
2303
81
197
162
2085
106
318
96
1590
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
1.4e+00
2.3e+00
—
—
—
3.0e+00
2.4e+00
cases:4.58%
controls:1.15%
cases:5.58%
controls:0.59%
—
—
—
—
—
—
cases:7.41%
controls:0.39%
cases:10.89%
controls:1.10%
11
26
229
2235
14
14
237
2347
—
—
—
18
9
225
2273
22
21
180
1887
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
7.0e-01
1.2e+00
2.0e+00
—
2.4e+00
1.4e+00
1.4e+00
cases:29.17%
controls:17.03%
cases:18.33%
controls:6.57%
cases:5.18%
controls:0.72%
—
—
cases:5.98%
controls:0.59%
cases:18.93%
controls:5.43%
cases:38.12%
controls:13.05%
70
385
170
1876
46
155
205
2206
13
17
238
2344
—
15
14
236
2340
46
124
197
2158
77
249
125
1659
Cathetrisation of artery
TPH07 [2001309747]
1.6e+00
2.0e+00
—
—
—
2.6e+00
2.9e+00
cases:12.92%
controls:2.92%
cases:5.18%
controls:0.72%
—
—
—
—
—
—
cases:3.29%
controls:0.26%
cases:8.42%
controls:0.52%
31
66
209
2195
13
17
238
2344
—
—
—
8
6
235
2276
17
10
185
1898
Abdominal ultrasound examination
JN3AE [2001305555]
1.9e+00
2.3e+00
—
—
—
2.6e+00
2.2e+00
cases:27.08%
controls:5.17%
cases:13.15%
controls:1.52%
—
—
—
—
—
—
cases:9.88%
controls:0.83%
cases:22.77%
controls:3.04%
65
117
175
2144
33
36
218
2325
—
—
—
24
19
219
2263
46
58
156
1850
Dentistry
C5 [903277]
2.0e+00
2.1e+00
—
—
—
2.3e+00
2.5e+00
cases:20.83%
controls:3.41%
cases:11.95%
controls:1.57%
—
—
—
—
—
—
cases:12.76%
controls:1.40%
cases:31.68%
controls:3.62%
50
77
190
2184
30
37
221
2324
—
—
—
31
32
212
2250
64
69
138
1839
Standard cardiac ultrasound examination
FM1AE [2001303278]
1.6e+00
2.5e+00
—
—
1.0e+50
2.5e+00
2.4e+00
cases:5.83%
controls:1.19%
cases:4.78%
controls:0.42%
—
—
—
—
cases:1.99%
controls:0.00%
cases:4.12%
controls:0.35%
cases:10.40%
controls:1.05%
14
27
226
2234
12
10
239
2351
—
—
5
0
246
2354
10
8
233
2274
21
20
181
1888
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
1.0e+00
1.7e+00
1.8e+00
—
2.3e+00
1.7e+00
2.3e+00
cases:17.50%
controls:6.99%
cases:11.16%
controls:2.33%
cases:1.99%
controls:0.34%
—
—
cases:3.19%
controls:0.34%
cases:7.41%
controls:1.40%
cases:21.78%
controls:2.83%
42
158
198
2103
28
55
223
2306
5
8
246
2353
—
8
8
243
2346
18
32
225
2250
44
54
158
1854
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
1.5e+00
1.9e+00
—
—
—
2.5e+00
3.1e+00
cases:5.00%
controls:1.19%
cases:5.58%
controls:0.85%
—
—
—
—
—
—
cases:4.94%
controls:0.44%
cases:11.88%
controls:0.63%
12
27
228
2234
14
20
237
2341
—
—
—
12
10
231
2272
24
12
178
1896
B lymphocytes [#/volume] in Blood
11130-2 [3000060]
1.5e+00
2.1e+00
—
—
—
2.3e+00
3.1e+00
cases:4.58%
controls:1.06%
cases:5.98%
controls:0.80%
—
—
—
—
—
—
cases:4.12%
controls:0.44%
cases:9.41%
controls:0.47%
11
24
229
2237
15
19
236
2342
—
—
—
10
10
233
2272
19
9
183
1899
CD3 cells [#/volume] in Blood
8122-4 [3011412]
1.4e+00
1.9e+00
—
—
—
2.5e+00
3.1e+00
cases:5.00%
controls:1.24%
cases:5.58%
controls:0.85%
—
—
—
—
—
—
cases:4.94%
controls:0.44%
cases:11.88%
controls:0.63%
12
28
228
2233
14
20
237
2341
—
—
—
12
10
231
2272
24
12
178
1896
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
1.5e+00
1.9e+00
—
—
—
2.5e+00
3.0e+00
cases:5.00%
controls:1.19%
cases:5.58%
controls:0.85%
—
—
—
—
—
—
cases:4.94%
controls:0.44%
cases:11.39%
controls:0.63%
12
27
228
2234
14
20
237
2341
—
—
—
12
10
231
2272
23
12
179
1896
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
1.5e+00
1.9e+00
—
—
—
2.4e+00
3.1e+00
cases:5.00%
controls:1.19%
cases:5.58%
controls:0.85%
—
—
—
—
—
—
cases:4.53%
controls:0.44%
cases:11.39%
controls:0.58%
12
27
228
2234
14
20
237
2341
—
—
—
11
10
232
2272
23
11
179
1897
Cathetrisation of vein
TPH04 [2001309597]
2.3e+00
1.9e+00
—
—
—
2.5e+00
2.2e+00
cases:19.58%
controls:2.48%
cases:3.98%
controls:0.64%
—
—
—
—
—
—
cases:4.94%
controls:0.44%
cases:15.35%
controls:1.89%
47
56
193
2205
10
15
241
2346
—
—
—
12
10
231
2272
31
36
171
1872
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
5.9e-01
1.4e+00
2.0e+00
1.0e+50
2.0e+00
1.5e+00
1.4e+00
cases:20.83%
controls:12.74%
cases:21.12%
controls:6.27%
cases:4.38%
controls:0.64%
cases:3.59%
controls:0.00%
cases:4.78%
controls:0.68%
cases:20.99%
controls:5.52%
cases:40.10%
controls:14.52%
50
288
190
1973
53
148
198
2213
11
15
240
2346
9
0
242
2361
12
16
239
2338
51
126
192
2156
81
277
121
1631
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
7.9e-01
1.3e+00
2.0e+00
—
2.0e+00
1.5e+00
1.3e+00
cases:30.83%
controls:16.85%
cases:22.31%
controls:7.50%
cases:6.37%
controls:0.93%
—
—
cases:6.37%
controls:0.89%
cases:23.05%
controls:6.44%
cases:39.60%
controls:15.20%
74
381
166
1880
56
177
195
2184
16
22
235
2339
—
16
21
235
2333
56
147
187
2135
80
290
122
1618
Alpha tocopherol [Moles/volume] in Serum or Plasma
14590-4 [3000208]
2.1e+00
1.8e+00
—
—
—
2.3e+00
2.6e+00
cases:5.83%
controls:0.75%
cases:4.38%
controls:0.76%
—
—
—
—
—
—
cases:3.29%
controls:0.35%
cases:8.42%
controls:0.68%
14
17
226
2244
11
18
240
2343
—
—
—
8
8
235
2274
17
13
185
1895
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
7.8e-01
1.3e+00
1.6e+00
—
2.0e+00
1.5e+00
1.6e+00
cases:30.83%
controls:17.03%
cases:22.31%
controls:7.54%
cases:6.77%
controls:1.44%
—
—
cases:8.76%
controls:1.32%
cases:23.87%
controls:6.35%
cases:46.53%
controls:14.99%
74
385
166
1876
56
178
195
2183
17
34
234
2327
—
22
31
229
2323
58
145
185
2137
94
286
108
1622
General anaesthesia
WX402 [2001310806]
1.3e+00
1.3e+00
—
—
2.7e+00
1.8e+00
1.6e+00
cases:13.75%
controls:4.16%
cases:6.77%
controls:1.95%
—
—
—
—
cases:3.19%
controls:0.21%
cases:10.29%
controls:1.93%
cases:19.80%
controls:4.72%
33
94
207
2167
17
46
234
2315
—
—
8
5
243
2349
25
44
218
2238
40
90
162
1818
Dental calculus supragingival
K03.64 [2000502689]
1.4e+00
1.5e+00
—
—
3.0e+00
1.5e+00
1.3e+00
cases:20.00%
controls:5.88%
cases:9.56%
controls:2.37%
—
—
—
—
cases:4.78%
controls:0.25%
cases:12.76%
controls:3.11%
cases:38.12%
controls:13.78%
48
133
192
2128
24
56
227
2305
—
—
12
6
239
2348
31
71
212
2211
77
263
125
1645
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
1.6e+00
2.0e+00
—
—
—
2.2e+00
2.9e+00
cases:15.00%
controls:3.41%
cases:9.16%
controls:1.36%
—
—
—
—
—
—
cases:7.00%
controls:0.83%
cases:14.36%
controls:0.94%
36
77
204
2184
23
32
228
2329
—
—
—
17
19
226
2263
29
18
173
1890
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.8e+00
2.4e+00
—
—
—
2.0e+00
2.4e+00
cases:11.67%
controls:2.08%
cases:8.37%
controls:0.80%
—
—
—
—
—
—
cases:4.12%
controls:0.57%
cases:10.89%
controls:1.10%
28
47
212
2214
21
19
230
2342
—
—
—
10
13
233
2269
22
21
180
1887
spironolactone; oral
C03DA01 [21601534]
3.2e+00
2.9e+00
—
—
—
2.5e+00
—
cases:8.75%
controls:0.40%
cases:5.98%
controls:0.34%
—
—
—
—
—
—
cases:3.70%
controls:0.31%
—
—
21
9
219
2252
15
8
236
2353
—
—
—
9
7
234
2275
—
Other stressful life events affecting family and household
Z63.7 [45537662]
1.5e+00
2.1e+00
—
—
—
2.6e+00
2.4e+00
cases:9.58%
controls:2.39%
cases:8.37%
controls:1.10%
—
—
—
—
—
—
cases:9.05%
controls:0.70%
cases:14.85%
controls:1.57%
23
54
217
2207
21
26
230
2335
—
—
—
22
16
221
2266
30
30
172
1878
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
1.8e+00
2.6e+00
—
—
—
2.2e+00
2.0e+00
cases:12.92%
controls:2.30%
cases:10.36%
controls:0.89%
—
—
—
—
—
—
cases:8.64%
controls:1.01%
cases:12.87%
controls:2.04%
31
52
209
2209
26
21
225
2340
—
—
—
21
23
222
2259
26
39
176
1869
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
1.4e+00
1.8e+00
1.6e+00
1.0e+50
2.0e+00
1.8e+00
1.6e+00
cases:16.67%
controls:4.91%
cases:13.55%
controls:2.50%
cases:2.39%
controls:0.51%
cases:2.39%
controls:0.00%
cases:2.79%
controls:0.38%
cases:13.17%
controls:2.54%
cases:22.77%
controls:5.45%
40
111
200
2150
34
59
217
2302
6
12
245
2349
6
0
245
2361
7
9
244
2345
32
58
211
2224
46
104
156
1804
Glomerular filtration rate (GFR) Isotope mesurement
KA1MN [2001305637]
3.6e+00
—
—
1.0e+50
—
—
4.9e+00
cases:21.25%
controls:0.71%
—
—
—
—
cases:5.58%
controls:0.00%
—
—
—
—
cases:26.73%
controls:0.26%
51
16
189
2245
—
—
14
0
237
2361
—
—
54
5
148
1903
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
6.0e-01
1.1e+00
2.1e+00
—
1.9e+00
1.4e+00
1.5e+00
cases:42.92%
controls:29.28%
cases:37.85%
controls:16.69%
cases:19.12%
controls:2.84%
—
—
cases:15.14%
controls:2.72%
cases:40.74%
controls:14.24%
cases:61.88%
controls:27.04%
103
662
137
1599
95
394
156
1967
48
67
203
2294
—
38
64
213
2290
99
325
144
1957
125
516
77
1392
Pediatric Gastroenterology
OMOP4822029 [45756810]
1.4e+00
1.8e+00
1.6e+00
1.0e+50
1.8e+00
1.7e+00
1.8e+00
cases:13.75%
controls:3.85%
cases:10.76%
controls:1.91%
cases:2.39%
controls:0.51%
cases:3.59%
controls:0.00%
cases:3.59%
controls:0.59%
cases:7.82%
controls:1.49%
cases:14.85%
controls:2.88%
33
87
207
2174
27
45
224
2316
6
12
245
2349
9
0
242
2361
9
14
242
2340
19
34
224
2248
30
55
172
1853
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.7e+00
2.1e+00
—
—
—
2.3e+00
2.4e+00
cases:16.25%
controls:3.32%
cases:7.17%
controls:0.93%
—
—
—
—
—
—
cases:5.35%
controls:0.57%
cases:11.88%
controls:1.21%
39
75
201
2186
18
22
233
2339
—
—
—
13
13
230
2269
24
23
178
1885
More than three and less than five hours
ZXE20 [2001311408]
1.6e+00
2.3e+00
—
—
—
2.4e+00
2.1e+00
cases:12.92%
controls:2.79%
cases:5.58%
controls:0.59%
—
—
—
—
—
—
cases:2.88%
controls:0.26%
cases:7.92%
controls:1.00%
31
63
209
2198
14
14
237
2347
—
—
—
7
6
236
2276
16
19
186
1889
Right side
ZXA00 [2001311346]
1.9e+00
2.0e+00
—
—
—
2.4e+00
2.1e+00
cases:14.17%
controls:2.39%
cases:5.18%
controls:0.72%
—
—
—
—
—
—
cases:3.29%
controls:0.31%
cases:7.43%
controls:0.94%
34
54
206
2207
13
17
238
2344
—
—
—
8
7
235
2275
15
18
187
1890
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
2.5e+00
3.2e+00
—
—
—
—
2.8e+00
cases:7.50%
controls:0.66%
cases:4.78%
controls:0.21%
—
—
—
—
—
—
—
—
cases:4.95%
controls:0.31%
18
15
222
2246
12
5
239
2356
—
—
—
—
10
6
192
1902
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
1.3e+00
1.8e+00
1.5e+00
—
1.9e+00
1.7e+00
1.7e+00
cases:15.83%
controls:4.69%
cases:13.55%
controls:2.41%
cases:2.39%
controls:0.55%
—
—
cases:2.79%
controls:0.42%
cases:13.17%
controls:2.67%
cases:22.77%
controls:5.35%
38
106
202
2155
34
57
217
2304
6
13
245
2348
—
7
10
244
2344
32
61
211
2221
46
102
156
1806
CD3-CD19+ cells/cells in Blood
15196-9 [3006245]
1.5e+00
2.0e+00
—
—
—
2.2e+00
2.9e+00
cases:4.58%
controls:1.11%
cases:5.98%
controls:0.89%
—
—
—
—
—
—
cases:4.12%
controls:0.48%
cases:9.90%
controls:0.63%
11
25
229
2236
15
21
236
2340
—
—
—
10
11
233
2271
20
12
182
1896
pH of Urine
2756-5 [3015736]
6.8e-01
1.3e+00
2.4e+00
—
2.1e+00
1.5e+00
1.1e+00
cases:13.33%
controls:7.25%
cases:13.15%
controls:3.81%
cases:4.38%
controls:0.42%
—
—
cases:3.59%
controls:0.47%
cases:16.05%
controls:3.99%
cases:27.23%
controls:11.16%
32
164
208
2097
33
90
218
2271
11
10
240
2351
—
9
11
242
2343
39
91
204
2191
55
213
147
1695
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
1.6e+00
2.2e+00
—
—
—
2.0e+00
2.5e+00
cases:15.42%
controls:3.45%
cases:9.16%
controls:1.14%
—
—
—
—
—
—
cases:7.00%
controls:1.01%
cases:16.83%
controls:1.57%
37
78
203
2183
23
27
228
2334
—
—
—
17
23
226
2259
34
30
168
1878
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.6e+00
2.1e+00
—
—
—
2.4e+00
2.1e+00
cases:5.00%
controls:1.06%
cases:4.38%
controls:0.55%
—
—
—
—
—
—
cases:2.47%
controls:0.22%
cases:5.94%
controls:0.73%
12
24
228
2237
11
13
240
2348
—
—
—
6
5
237
2277
12
14
190
1894
Removal of fixed intravenous catheter
TPH90 [2001309607]
2.6e+00
3.6e+00
—
—
—
1.0e+50
2.1e+00
cases:12.50%
controls:1.06%
cases:8.37%
controls:0.25%
—
—
—
—
—
—
cases:4.12%
controls:0.00%
cases:2.97%
controls:0.37%
30
24
210
2237
21
6
230
2355
—
—
—
10
0
233
2282
6
7
196
1901
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
7.2e-01
1.1e+00
1.8e+00
—
1.8e+00
1.4e+00
1.4e+00
cases:41.67%
controls:25.83%
cases:36.25%
controls:15.76%
cases:15.94%
controls:3.01%
—
—
cases:14.74%
controls:2.89%
cases:40.33%
controls:13.76%
cases:59.41%
controls:27.31%
100
584
140
1677
91
372
160
1989
40
71
211
2290
—
37
68
214
2286
98
314
145
1968
120
521
82
1387
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
6.1e-01
1.3e+00
2.4e+00
—
2.0e+00
1.4e+00
1.0e+00
cases:15.00%
controls:8.76%
cases:14.74%
controls:4.49%
cases:5.18%
controls:0.51%
—
—
cases:4.38%
controls:0.59%
cases:17.70%
controls:4.91%
cases:30.20%
controls:13.21%
36
198
204
2063
37
106
214
2255
13
12
238
2349
—
11
14
240
2340
43
112
200
2170
61
252
141
1656
Acute tubulo-interstitial nephritis
N10 [45543856]
1.3e+00
2.3e+00
—
—
—
2.4e+00
2.2e+00
cases:5.00%
controls:1.42%
cases:2.79%
controls:0.30%
—
—
—
—
—
—
cases:2.47%
controls:0.22%
cases:3.96%
controls:0.47%
12
32
228
2229
7
7
244
2354
—
—
—
6
5
237
2277
8
9
194
1899
losartan; oral
C09CA01 [21601824]
1.8e+00
1.8e+00
—
—
-1.0e+50
1.9e+00
2.7e+00
cases:4.58%
controls:0.75%
cases:3.59%
controls:0.64%
—
—
—
—
cases:0.00%
controls:0.42%
cases:3.29%
controls:0.53%
cases:4.46%
controls:0.31%
11
17
229
2244
9
15
242
2346
—
—
0
10
251
2344
8
12
235
2270
9
6
193
1902
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
-6.4e-02
1.2e+00
2.4e+00
—
2.4e+00
1.2e+00
9.2e-01
cases:6.25%
controls:6.63%
cases:7.17%
controls:2.20%
cases:2.39%
controls:0.21%
—
—
cases:3.19%
controls:0.30%
cases:7.82%
controls:2.59%
cases:16.83%
controls:7.49%
15
150
225
2111
18
52
233
2309
6
5
245
2356
—
8
7
243
2347
19
59
224
2223
34
143
168
1765
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
5.8e-01
1.3e+00
2.4e+00
—
2.0e+00
1.4e+00
1.0e+00
cases:14.58%
controls:8.71%
cases:14.34%
controls:4.40%
cases:5.18%
controls:0.51%
—
—
cases:4.38%
controls:0.59%
cases:17.70%
controls:4.91%
cases:30.20%
controls:13.36%
35
197
205
2064
36
104
215
2257
13
12
238
2349
—
11
14
240
2340
43
112
200
2170
61
255
141
1653
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5.8e-01
1.3e+00
2.4e+00
—
2.0e+00
1.4e+00
1.0e+00
cases:14.58%
controls:8.76%
cases:14.34%
controls:4.36%
cases:5.18%
controls:0.51%
—
—
cases:4.38%
controls:0.59%
cases:17.28%
controls:4.95%
cases:29.70%
controls:12.95%
35
198
205
2063
36
103
215
2258
13
12
238
2349
—
11
14
240
2340
42
113
201
2169
60
247
142
1661
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
5.9e-01
1.2e+00
2.0e+00
—
1.7e+00
1.3e+00
1.3e+00
cases:40.83%
controls:27.64%
cases:35.86%
controls:14.95%
cases:15.54%
controls:2.46%
—
—
cases:12.35%
controls:2.46%
cases:33.74%
controls:11.83%
cases:55.45%
controls:25.10%
98
625
142
1636
90
353
161
2008
39
58
212
2303
—
31
58
220
2296
82
270
161
2012
112
479
90
1429
Gas panel - Capillary blood
24337-8 [3022313]
9.5e-01
1.5e+00
1.5e+00
—
1.8e+00
1.8e+00
2.1e+00
cases:20.83%
controls:9.20%
cases:14.34%
controls:3.60%
cases:3.19%
controls:0.76%
—
—
cases:3.19%
controls:0.55%
cases:11.52%
controls:2.10%
cases:20.79%
controls:3.25%
50
208
190
2053
36
85
215
2276
8
18
243
2343
—
8
13
243
2341
28
48
215
2234
42
62
160
1846
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
1.7e+00
1.6e+00
—
—
—
2.5e+00
2.3e+00
cases:12.08%
controls:2.48%
cases:6.37%
controls:1.31%
—
—
—
—
—
—
cases:7.41%
controls:0.66%
cases:11.88%
controls:1.36%
29
56
211
2205
16
31
235
2330
—
—
—
18
15
225
2267
24
26
178
1882
Oral Surgery
19 [38004464]
2.3e+00
—
—
—
—
3.1e+00
2.7e+00
cases:5.42%
controls:0.57%
—
—
—
—
—
—
—
—
cases:4.53%
controls:0.22%
cases:10.40%
controls:0.79%
13
13
227
2248
—
—
—
—
11
5
232
2277
21
15
181
1893
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
4.4e+00
—
—
1.0e+50
1.0e+50
—
3.6e+00
cases:15.00%
controls:0.22%
—
—
—
—
cases:4.38%
controls:0.00%
cases:3.59%
controls:0.00%
—
—
cases:21.78%
controls:0.73%
36
5
204
2256
—
—
11
0
240
2361
9
0
242
2354
—
44
14
158
1894
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
5.9e-01
1.1e+00
2.0e+00
—
1.7e+00
1.3e+00
1.3e+00
cases:40.83%
controls:27.69%
cases:36.25%
controls:15.33%
cases:15.54%
controls:2.54%
—
—
cases:11.95%
controls:2.46%
cases:33.74%
controls:11.96%
cases:55.45%
controls:25.58%
98
626
142
1635
91
362
160
1999
39
60
212
2301
—
30
58
221
2296
82
273
161
2009
112
488
90
1420
Retinol [Moles/volume] in Serum or Plasma
14905-4 [3013005]
2.0e+00
1.5e+00
—
—
—
1.9e+00
2.4e+00
cases:6.67%
controls:0.97%
cases:4.38%
controls:0.97%
—
—
—
—
—
—
cases:3.29%
controls:0.48%
cases:9.41%
controls:0.89%
16
22
224
2239
11
23
240
2338
—
—
—
8
11
235
2271
19
17
183
1891
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
—
2.1e+00
—
—
—
3.0e+00
2.7e+00
—
—
cases:2.79%
controls:0.34%
—
—
—
—
—
—
cases:4.12%
controls:0.22%
cases:7.92%
controls:0.58%
—
7
8
244
2353
—
—
—
10
5
233
2277
16
11
186
1897
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
1.4e+00
2.4e+00
—
—
—
2.7e+00
2.7e+00
cases:3.75%
controls:0.97%
cases:5.58%
controls:0.55%
—
—
—
—
—
—
cases:4.94%
controls:0.35%
cases:9.41%
controls:0.68%
9
22
231
2239
14
13
237
2348
—
—
—
12
8
231
2274
19
13
183
1895
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
8.8e-01
1.4e+00
1.4e+00
—
1.7e+00
1.8e+00
1.9e+00
cases:21.25%
controls:10.08%
cases:15.54%
controls:4.28%
cases:3.19%
controls:0.80%
—
—
cases:3.98%
controls:0.72%
cases:14.81%
controls:2.85%
cases:24.26%
controls:4.45%
51
228
189
2033
39
101
212
2260
8
19
243
2342
—
10
17
241
2337
36
65
207
2217
49
85
153
1823
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
1.4e+00
2.3e+00
—
—
—
2.8e+00
2.6e+00
cases:3.75%
controls:0.97%
cases:5.58%
controls:0.59%
—
—
—
—
—
—
cases:4.94%
controls:0.31%
cases:8.91%
controls:0.73%
9
22
231
2239
14
14
237
2347
—
—
—
12
7
231
2275
18
14
184
1894
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
8.8e-01
1.4e+00
1.3e+00
—
1.7e+00
1.8e+00
1.9e+00
cases:21.25%
controls:10.08%
cases:14.74%
controls:4.28%
cases:2.79%
controls:0.80%
—
—
cases:3.59%
controls:0.68%
cases:13.58%
controls:2.63%
cases:24.26%
controls:4.40%
51
228
189
2033
37
101
214
2260
7
19
244
2342
—
9
16
242
2338
33
60
210
2222
49
84
153
1824
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2.1e+00
2.3e+00
—
—
—
—
3.2e+00
cases:7.92%
controls:1.02%
cases:5.18%
controls:0.55%
—
—
—
—
—
—
—
—
cases:5.94%
controls:0.26%
19
23
221
2238
13
13
238
2348
—
—
—
—
12
5
190
1903
pH of Capillary blood
2745-8 [3009343]
8.8e-01
1.4e+00
1.4e+00
—
1.6e+00
1.7e+00
1.9e+00
cases:21.25%
controls:10.08%
cases:15.54%
controls:4.28%
cases:3.19%
controls:0.80%
—
—
cases:3.59%
controls:0.72%
cases:13.99%
controls:2.85%
cases:24.26%
controls:4.40%
51
228
189
2033
39
101
212
2260
8
19
243
2342
—
9
17
242
2337
34
65
209
2217
49
84
153
1824
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
1.6e+00
1.6e+00
—
—
—
1.7e+00
2.6e+00
cases:15.83%
controls:3.67%
cases:7.17%
controls:1.52%
—
—
—
—
—
—
cases:4.94%
controls:0.92%
cases:10.89%
controls:0.89%
38
83
202
2178
18
36
233
2325
—
—
—
12
21
231
2261
22
17
180
1891
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
8.7e-01
1.4e+00
1.3e+00
—
1.7e+00
1.7e+00
1.9e+00
cases:20.00%
controls:9.51%
cases:13.55%
controls:3.90%
cases:2.79%
controls:0.80%
—
—
cases:3.19%
controls:0.59%
cases:11.93%
controls:2.32%
cases:19.31%
controls:3.56%
48
215
192
2046
34
92
217
2269
7
19
244
2342
—
8
14
243
2340
29
53
214
2229
39
68
163
1840
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
2.4e+00
—
—
—
—
2.5e+00
2.6e+00
cases:5.00%
controls:0.49%
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.31%
cases:7.43%
controls:0.58%
12
11
228
2250
—
—
—
—
9
7
234
2275
15
11
187
1897
Pediatric Cardiology
OMOP4821938 [45756805]
1.1e+00
1.4e+00
1.4e+00
1.0e+50
1.9e+00
1.6e+00
1.6e+00
cases:21.25%
controls:8.05%
cases:14.34%
controls:4.02%
cases:2.79%
controls:0.72%
cases:3.19%
controls:0.00%
cases:3.98%
controls:0.64%
cases:12.76%
controls:2.98%
cases:21.29%
controls:5.29%
51
182
189
2079
36
95
215
2266
7
17
244
2344
8
0
243
2361
10
15
241
2339
31
68
212
2214
43
101
159
1807
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
8.3e-01
1.4e+00
1.3e+00
—
1.7e+00
1.7e+00
1.8e+00
cases:20.00%
controls:9.82%
cases:14.74%
controls:4.02%
cases:2.79%
controls:0.76%
—
—
cases:3.19%
controls:0.59%
cases:12.35%
controls:2.50%
cases:19.80%
controls:3.83%
48
222
192
2039
37
95
214
2266
7
18
244
2343
—
8
14
243
2340
30
57
213
2225
40
73
162
1835
Bacteria identified in Blood by Culture
600-7 [3023368]
1.3e+00
1.9e+00
—
—
—
2.1e+00
2.2e+00
cases:14.17%
controls:4.51%
cases:9.16%
controls:1.48%
—
—
—
—
—
—
cases:7.00%
controls:0.88%
cases:16.34%
controls:2.15%
34
102
206
2159
23
35
228
2326
—
—
—
17
20
226
2262
33
41
169
1867
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.6e+00
2.3e+00
—
—
—
1.9e+00
1.6e+00
cases:8.33%
controls:1.72%
cases:7.57%
controls:0.80%
—
—
—
—
—
—
cases:3.29%
controls:0.48%
cases:5.94%
controls:1.31%
20
39
220
2222
19
19
232
2342
—
—
—
8
11
235
2271
12
25
190
1883
Extended examination of mouth
SAA03 [2001310276]
9.8e-01
1.1e+00
—
1.0e+50
2.2e+00
1.6e+00
1.6e+00
cases:36.67%
controls:17.87%
cases:21.91%
controls:8.34%
—
—
cases:27.49%
controls:0.00%
cases:6.77%
controls:0.81%
cases:31.28%
controls:8.41%
cases:67.82%
controls:30.77%
88
404
152
1857
55
197
196
2164
—
69
0
182
2361
17
19
234
2335
76
192
167
2090
137
587
65
1321
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
7.3e-01
1.9e+00
—
—
—
2.9e+00
2.6e+00
cases:2.08%
controls:1.02%
cases:2.79%
controls:0.42%
—
—
—
—
—
—
cases:4.53%
controls:0.26%
cases:9.90%
controls:0.79%
5
23
235
2238
7
10
244
2351
—
—
—
11
6
232
2276
20
15
182
1893
Approximal wear
K03.00 [2000502665]
2.0e+00
—
—
1.0e+50
—
2.6e+00
2.9e+00
cases:3.33%
controls:0.49%
—
—
—
—
cases:7.57%
controls:0.00%
—
—
cases:5.35%
controls:0.44%
cases:13.37%
controls:0.84%
8
11
232
2250
—
—
19
0
232
2361
—
13
10
230
2272
27
16
175
1892
Bacteria identified in Isolate by Culture
43409-2 [3042936]
1.2e+00
2.0e+00
—
—
—
2.0e+00
2.2e+00
cases:7.50%
controls:2.48%
cases:5.58%
controls:0.80%
—
—
—
—
—
—
cases:2.88%
controls:0.39%
cases:8.42%
controls:1.00%
18
56
222
2205
14
19
237
2342
—
—
—
7
9
236
2273
17
19
185
1889
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
5.7e-01
2.5e+00
—
—
—
2.3e+00
2.5e+00
cases:2.08%
controls:1.19%
cases:3.98%
controls:0.34%
—
—
—
—
—
—
cases:2.88%
controls:0.31%
cases:7.92%
controls:0.68%
5
27
235
2234
10
8
241
2353
—
—
—
7
7
236
2275
16
13
186
1895
Bloodpressure measurement
XF600 [2001303376]
1.3e+00
1.4e+00
—
—
—
2.3e+00
2.3e+00
cases:10.42%
controls:3.10%
cases:4.78%
controls:1.19%
—
—
—
—
—
—
cases:6.58%
controls:0.70%
cases:13.37%
controls:1.57%
25
70
215
2191
12
28
239
2333
—
—
—
16
16
227
2266
27
30
175
1878
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
1.2e+00
1.5e+00
—
—
—
2.1e+00
2.5e+00
cases:11.67%
controls:3.76%
cases:7.57%
controls:1.78%
—
—
—
—
—
—
cases:9.47%
controls:1.31%
cases:19.80%
controls:1.99%
28
85
212
2176
19
42
232
2319
—
—
—
23
30
220
2252
40
38
162
1870
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.5e+00
2.0e+00
—
—
—
2.1e+00
1.5e+00
cases:9.58%
controls:2.26%
cases:7.97%
controls:1.14%
—
—
—
—
—
—
cases:5.35%
controls:0.66%
cases:9.41%
controls:2.31%
23
51
217
2210
20
27
231
2334
—
—
—
13
15
230
2267
19
44
183
1864
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
8.7e-01
1.4e+00
2.1e+00
—
2.0e+00
1.6e+00
1.2e+00
cases:11.25%
controls:5.04%
cases:11.16%
controls:2.92%
cases:3.59%
controls:0.47%
—
—
cases:2.39%
controls:0.34%
cases:13.17%
controls:2.98%
cases:23.27%
controls:8.44%
27
114
213
2147
28
69
223
2292
9
11
242
2350
—
6
8
245
2346
32
68
211
2214
47
161
155
1747
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
1.3e+00
1.6e+00
—
—
—
2.0e+00
2.3e+00
cases:6.25%
controls:1.77%
cases:5.58%
controls:1.14%
—
—
—
—
—
—
cases:6.17%
controls:0.92%
cases:10.89%
controls:1.26%
15
40
225
2221
14
27
237
2334
—
—
—
15
21
228
2261
22
24
180
1884
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.6e+00
1.7e+00
1.8e+00
—
—
1.8e+00
1.9e+00
cases:13.75%
controls:3.14%
cases:8.37%
controls:1.57%
cases:1.99%
controls:0.34%
—
—
—
—
cases:7.00%
controls:1.18%
cases:21.78%
controls:3.83%
33
71
207
2190
21
37
230
2324
5
8
246
2353
—
—
17
27
226
2255
44
73
158
1835
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
1.1e+00
1.3e+00
2.2e+00
1.0e+50
1.7e+00
1.5e+00
1.2e+00
cases:10.83%
controls:4.07%
cases:9.56%
controls:2.84%
cases:3.19%
controls:0.38%
cases:1.99%
controls:0.00%
cases:1.99%
controls:0.38%
cases:11.52%
controls:2.89%
cases:21.78%
controls:8.07%
26
92
214
2169
24
67
227
2294
8
9
243
2352
5
0
246
2361
5
9
246
2345
28
66
215
2216
44
154
158
1754
warfarin; oral, parenteral
B01AA03 [21600965]
2.4e+00
2.5e+00
—
—
—
2.3e+00
—
cases:6.25%
controls:0.62%
cases:4.38%
controls:0.38%
—
—
—
—
—
—
cases:3.29%
controls:0.35%
—
—
15
14
225
2247
11
9
240
2352
—
—
—
8
8
235
2274
—
CD3+CD8+ (T8 suppressor) cells/cells in Blood
8101-8 [3007449]
1.4e+00
1.9e+00
—
—
—
2.4e+00
2.9e+00
cases:4.17%
controls:1.11%
cases:5.18%
controls:0.85%
—
—
—
—
—
—
cases:4.12%
controls:0.39%
cases:9.41%
controls:0.58%
10
25
230
2236
13
20
238
2341
—
—
—
10
9
233
2273
19
11
183
1897
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
1.6e+00
2.0e+00
—
—
—
2.0e+00
1.5e+00
cases:10.00%
controls:2.21%
cases:7.57%
controls:1.10%
—
—
—
—
—
—
cases:4.94%
controls:0.70%
cases:9.41%
controls:2.25%
24
50
216
2211
19
26
232
2335
—
—
—
12
16
231
2266
19
43
183
1865
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
1.6e+00
1.6e+00
—
—
—
1.9e+00
2.0e+00
cases:10.42%
controls:2.26%
cases:7.57%
controls:1.65%
—
—
—
—
—
—
cases:3.29%
controls:0.53%
cases:11.39%
controls:1.68%
25
51
215
2210
19
39
232
2322
—
—
—
8
12
235
2270
23
32
179
1876
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
—
2.1e+00
—
—
—
2.4e+00
2.5e+00
—
—
cases:2.79%
controls:0.34%
—
—
—
—
—
—
cases:3.29%
controls:0.31%
cases:7.43%
controls:0.63%
—
7
8
244
2353
—
—
—
8
7
235
2275
15
12
187
1896
Counselling and guidance which enhance independent living
R2130 [2001310196]
1.6e+00
1.4e+00
—
—
—
1.7e+00
2.3e+00
cases:21.25%
controls:4.95%
cases:7.17%
controls:1.82%
—
—
—
—
—
—
cases:7.00%
controls:1.40%
cases:12.38%
controls:1.36%
51
112
189
2149
18
43
233
2318
—
—
—
17
32
226
2250
25
26
177
1882
General evaluation of the need for rehabilitation
R1100 [2001310172]
1.8e+00
2.5e+00
—
—
—
—
2.8e+00
cases:8.33%
controls:1.46%
cases:4.38%
controls:0.38%
—
—
—
—
—
—
—
—
cases:8.42%
controls:0.58%
20
33
220
2228
11
9
240
2352
—
—
—
—
17
11
185
1897
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
4.2e-01
1.6e+00
1.8e+00
—
2.3e+00
1.6e+00
1.5e+00
cases:5.42%
controls:3.63%
cases:6.77%
controls:1.40%
cases:1.99%
controls:0.34%
—
—
cases:2.39%
controls:0.25%
cases:6.58%
controls:1.36%
cases:19.31%
controls:4.98%
13
82
227
2179
17
33
234
2328
5
8
246
2353
—
6
6
245
2348
16
31
227
2251
39
95
163
1813
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
8.3e-01
1.6e+00
1.5e+00
—
1.7e+00
1.5e+00
1.4e+00
cases:18.75%
controls:9.11%
cases:15.94%
controls:3.85%
cases:3.59%
controls:0.85%
—
—
cases:3.98%
controls:0.72%
cases:15.23%
controls:3.94%
cases:27.23%
controls:8.23%
45
206
195
2055
40
91
211
2270
9
20
242
2341
—
10
17
241
2337
37
90
206
2192
55
157
147
1751
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
1.4e+00
1.7e+00
—
—
—
2.0e+00
1.9e+00
cases:10.00%
controls:2.79%
cases:6.77%
controls:1.27%
—
—
—
—
—
—
cases:5.76%
controls:0.83%
cases:10.40%
controls:1.62%
24
63
216
2198
17
30
234
2331
—
—
—
14
19
229
2263
21
31
181
1877
Blasts/Leukocytes in Blood
26446-5 [3025159]
—
2.3e+00
—
—
—
2.3e+00
2.5e+00
—
—
cases:3.19%
controls:0.34%
—
—
—
—
—
—
cases:2.47%
controls:0.26%
cases:7.43%
controls:0.68%
—
8
8
243
2353
—
—
—
6
6
237
2276
15
13
187
1895
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
1.3e+00
1.9e+00
—
—
—
2.3e+00
2.9e+00
cases:4.17%
controls:1.19%
cases:5.18%
controls:0.85%
—
—
—
—
—
—
cases:4.12%
controls:0.44%
cases:9.90%
controls:0.63%
10
27
230
2234
13
20
238
2341
—
—
—
10
10
233
2272
20
12
182
1896
Bile acid [Moles/volume] in Serum --fasting
35562-8 [3034274]
1.3e+00
1.9e+00
—
—
—
2.1e+00
2.9e+00
cases:4.17%
controls:1.19%
cases:3.19%
controls:0.47%
—
—
—
—
—
—
cases:3.29%
controls:0.39%
cases:9.90%
controls:0.63%
10
27
230
2234
8
11
243
2350
—
—
—
8
9
235
2273
20
12
182
1896
sildenafil; oral
G04BE03 [21602648]
2.0e+00
2.7e+00
—
—
—
—
2.3e+00
cases:5.00%
controls:0.71%
cases:3.59%
controls:0.25%
—
—
—
—
—
—
—
—
cases:2.97%
controls:0.31%
12
16
228
2245
9
6
242
2355
—
—
—
—
6
6
196
1902
BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32284-2 [3000504]
—
3.4e+00
—
1.0e+50
—
3.5e+00
—
—
—
cases:7.17%
controls:0.25%
—
—
cases:3.19%
controls:0.00%
—
—
cases:7.00%
controls:0.22%
—
—
—
18
6
233
2355
—
8
0
243
2361
—
17
5
226
2277
—
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
1.6e+00
1.4e+00
—
—
—
2.2e+00
3.1e+00
cases:5.83%
controls:1.24%
cases:2.39%
controls:0.59%
—
—
—
—
—
—
cases:4.53%
controls:0.53%
cases:12.38%
controls:0.63%
14
28
226
2233
6
14
245
2347
—
—
—
11
12
232
2270
25
12
177
1896
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
1.3e+00
1.9e+00
—
—
—
2.2e+00
2.9e+00
cases:4.17%
controls:1.19%
cases:5.18%
controls:0.85%
—
—
—
—
—
—
cases:4.12%
controls:0.48%
cases:9.90%
controls:0.63%
10
27
230
2234
13
20
238
2341
—
—
—
10
11
233
2271
20
12
182
1896
Other minor procedure in endocrine surgery
TBW99 [2001300856]
1.7e+00
2.7e+00
—
—
—
—
2.5e+00
cases:6.25%
controls:1.19%
cases:3.59%
controls:0.25%
—
—
—
—
—
—
—
—
cases:6.44%
controls:0.58%
15
27
225
2234
9
6
242
2355
—
—
—
—
13
11
189
1897
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.4e+00
1.7e+00
—
—
—
1.6e+00
2.1e+00
cases:13.33%
controls:3.58%
cases:9.56%
controls:1.91%
—
—
—
—
—
—
cases:7.82%
controls:1.62%
cases:16.34%
controls:2.36%
32
81
208
2180
24
45
227
2316
—
—
—
19
37
224
2245
33
45
169
1863
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
1.1e+00
1.4e+00
1.6e+00
1.0e+50
1.5e+00
1.4e+00
1.4e+00
cases:22.50%
controls:8.85%
cases:17.13%
controls:4.91%
cases:3.98%
controls:0.85%
cases:2.39%
controls:0.00%
cases:3.59%
controls:0.85%
cases:18.93%
controls:5.48%
cases:36.63%
controls:12.63%
54
200
186
2061
43
116
208
2245
10
20
241
2341
6
0
245
2361
9
20
242
2334
46
125
197
2157
74
241
128
1667
High dependency care
WX882 [2001310847]
1.8e+00
1.8e+00
—
—
—
—
3.2e+00
cases:15.83%
controls:2.92%
cases:4.38%
controls:0.72%
—
—
—
—
—
—
—
—
cases:6.93%
controls:0.31%
38
66
202
2195
11
17
240
2344
—
—
—
—
14
6
188
1902
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
JN3DE [2001305565]
3.0e+00
—
—
—
—
1.0e+50
3.8e+00
cases:9.17%
controls:0.49%
—
—
—
—
—
—
—
—
cases:4.53%
controls:0.00%
cases:11.88%
controls:0.31%
22
11
218
2250
—
—
—
—
11
0
232
2282
24
6
178
1902
Urgent procedure
ZXD05 [2001311386]
2.1e+00
2.6e+00
—
—
—
1.5e+00
2.0e+00
cases:25.42%
controls:3.94%
cases:7.97%
controls:0.64%
—
—
—
—
—
—
cases:2.47%
controls:0.57%
cases:9.90%
controls:1.42%
61
89
179
2172
20
15
231
2346
—
—
—
6
13
237
2269
20
27
182
1881
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
3.6e+00
—
—
—
—
1.0e+50
3.1e+00
cases:7.50%
controls:0.22%
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.00%
cases:7.92%
controls:0.37%
18
5
222
2256
—
—
—
—
5
0
238
2282
16
7
186
1901
Emergency Room Visit
ER [9203]
1.1e+00
1.4e+00
1.4e+00
—
7.1e-01
1.5e+00
1.3e+00
cases:67.50%
controls:41.26%
cases:34.66%
controls:11.90%
cases:5.18%
controls:1.27%
—
—
cases:3.98%
controls:2.00%
cases:31.69%
controls:9.55%
cases:52.97%
controls:22.85%
162
933
78
1328
87
281
164
2080
13
30
238
2331
—
10
47
241
2307
77
218
166
2064
107
436
95
1472
Ultrasound measurement of residual urine
KC1EE [2001305918]
2.3e+00
2.6e+00
—
—
—
—
1.8e+00
cases:7.50%
controls:0.80%
cases:3.19%
controls:0.25%
—
—
—
—
—
—
—
—
cases:4.95%
controls:0.84%
18
18
222
2243
8
6
243
2355
—
—
—
—
10
16
192
1892
Caries of dentine
K02.1 [45548134]
8.7e-01
1.3e+00
1.1e+00
1.0e+50
2.3e+00
1.2e+00
9.6e-01
cases:30.00%
controls:15.17%
cases:21.51%
controls:6.86%
cases:2.39%
controls:0.80%
cases:23.11%
controls:0.00%
cases:9.96%
controls:1.15%
cases:20.99%
controls:7.10%
cases:48.51%
controls:26.47%
72
343
168
1918
54
162
197
2199
6
19
245
2342
58
0
193
2361
25
27
226
2327
51
162
192
2120
98
505
104
1403
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
1.4e+00
1.7e+00
—
—
—
1.9e+00
1.5e+00
cases:18.75%
controls:5.17%
cases:10.76%
controls:2.12%
—
—
—
—
—
—
cases:10.29%
controls:1.62%
cases:19.80%
controls:5.03%
45
117
195
2144
27
50
224
2311
—
—
—
25
37
218
2245
40
96
162
1812
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.4e+00
1.9e+00
—
—
—
1.9e+00
1.5e+00
cases:9.58%
controls:2.65%
cases:7.97%
controls:1.27%
—
—
—
—
—
—
cases:5.35%
controls:0.83%
cases:9.90%
controls:2.46%
23
60
217
2201
20
30
231
2331
—
—
—
13
19
230
2263
20
47
182
1861
Psychiatric monitoring contact
IGY02 [2001304322]
1.5e+00
1.7e+00
—
—
—
2.0e+00
1.4e+00
cases:5.42%
controls:1.24%
cases:3.98%
controls:0.76%
—
—
—
—
—
—
cases:3.70%
controls:0.53%
cases:7.92%
controls:1.99%
13
28
227
2233
10
18
241
2343
—
—
—
9
12
234
2270
16
38
186
1870
Fractional oxyhemoglobin in Venous blood
2716-9 [3019230]
1.7e+00
2.5e+00
—
—
—
—
2.4e+00
cases:3.33%
controls:0.62%
cases:3.98%
controls:0.34%
—
—
—
—
—
—
—
—
cases:3.96%
controls:0.37%
8
14
232
2247
10
8
241
2353
—
—
—
—
8
7
194
1901
Ambulatory ECG
XF404 [2001303370]
2.0e+00
2.1e+00
—
—
—
2.1e+00
2.4e+00
cases:7.50%
controls:1.11%
cases:2.79%
controls:0.34%
—
—
—
—
—
—
cases:2.06%
controls:0.26%
cases:3.47%
controls:0.31%
18
25
222
2236
7
8
244
2353
—
—
—
5
6
238
2276
7
6
195
1902
Other chronic renal failure
N18.8 [45534123]
3.4e+00
—
—
—
—
—
3.2e+00
cases:7.08%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:6.93%
controls:0.31%
17
6
223
2255
—
—
—
—
—
14
6
188
1902
Bone marrow biopsy
XW000 [2001310618]
2.7e+00
3.6e+00
—
—
1.0e+50
—
—
cases:8.75%
controls:0.62%
cases:7.57%
controls:0.21%
—
—
—
—
cases:1.99%
controls:0.00%
—
—
—
—
21
14
219
2247
19
5
232
2356
—
—
5
0
246
2354
—
—
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
3.0e+00
3.4e+00
—
—
—
—
—
cases:6.67%
controls:0.35%
cases:7.97%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
16
8
224
2253
20
7
231
2354
—
—
—
—
—
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
1.3e+00
1.8e+00
—
—
—
1.7e+00
1.6e+00
cases:6.67%
controls:1.99%
cases:5.18%
controls:0.93%
—
—
—
—
—
—
cases:4.12%
controls:0.74%
cases:9.41%
controls:2.10%
16
45
224
2216
13
22
238
2339
—
—
—
10
17
233
2265
19
40
183
1868
calcium carbonate; oral
A12AA04 [21600863]
2.8e+00
3.5e+00
—
—
1.0e+50
—
—
cases:10.83%
controls:0.75%
cases:7.97%
controls:0.25%
—
—
—
—
cases:1.99%
controls:0.00%
—
—
—
—
26
17
214
2244
20
6
231
2355
—
—
5
0
246
2354
—
—
calcium carbonate
A02AC01 [21600065]
2.8e+00
3.5e+00
—
—
1.0e+50
—
—
cases:10.83%
controls:0.75%
cases:7.97%
controls:0.25%
—
—
—
—
cases:1.99%
controls:0.00%
—
—
—
—
26
17
214
2244
20
6
231
2355
—
—
5
0
246
2354
—
—
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.1e+00
2.0e+00
—
—
—
1.6e+00
1.6e+00
cases:6.67%
controls:2.30%
cases:3.59%
controls:0.51%
—
—
—
—
—
—
cases:3.70%
controls:0.74%
cases:8.42%
controls:1.89%
16
52
224
2209
9
12
242
2349
—
—
—
9
17
234
2265
17
36
185
1872
Urinary tract ultrasound examination
KH1AE [2001306329]
1.7e+00
1.9e+00
—
—
—
—
2.6e+00
cases:7.50%
controls:1.42%
cases:3.98%
controls:0.59%
—
—
—
—
—
—
—
—
cases:8.42%
controls:0.68%
18
32
222
2229
10
14
241
2347
—
—
—
—
17
13
185
1895
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
2.7e-01
7.0e-01
1.7e+00
—
1.8e+00
1.1e+00
9.7e-01
cases:44.58%
controls:37.95%
cases:41.43%
controls:25.92%
cases:20.72%
controls:4.70%
—
—
cases:19.12%
controls:3.61%
cases:43.21%
controls:20.95%
cases:60.89%
controls:37.16%
107
858
133
1403
104
612
147
1749
52
111
199
2250
—
48
85
203
2269
105
478
138
1804
123
709
79
1199
Fever, unspecified
R50.9 [45582716]
1.4e+00
1.7e+00
—
—
—
1.9e+00
1.3e+00
cases:21.67%
controls:6.50%
cases:9.96%
controls:2.08%
—
—
—
—
—
—
cases:9.05%
controls:1.45%
cases:11.39%
controls:3.46%
52
147
188
2114
25
49
226
2312
—
—
—
22
33
221
2249
23
66
179
1842
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
4.1e-01
9.8e-01
1.6e+00
—
1.5e+00
1.0e+00
1.0e+00
cases:12.50%
controls:8.67%
cases:12.35%
controls:5.04%
cases:4.78%
controls:0.97%
—
—
cases:4.78%
controls:1.06%
cases:14.81%
controls:5.83%
cases:24.75%
controls:10.59%
30
196
210
2065
31
119
220
2242
12
23
239
2338
—
12
25
239
2329
36
133
207
2149
50
202
152
1706
Laboratory Visit
OMOP4822461 [32036]
6.5e-02
2.9e-01
1.3e+00
3.1e+00
1.3e+00
5.7e-01
4.2e-01
cases:51.25%
controls:49.62%
cases:50.60%
controls:43.29%
cases:29.88%
controls:10.67%
cases:11.95%
controls:0.64%
cases:27.49%
controls:9.69%
cases:52.67%
controls:38.61%
cases:72.28%
controls:63.10%
123
1122
117
1139
127
1022
124
1339
75
252
176
2109
30
15
221
2346
69
228
182
2126
128
881
115
1401
146
1204
56
704
Paediatric neurology
421 [44777781]
1.0e+00
9.5e-01
1.0e+00
—
1.0e+00
9.9e-01
1.2e+00
cases:37.92%
controls:18.18%
cases:26.69%
controls:12.37%
cases:6.77%
controls:2.58%
—
—
cases:7.17%
controls:2.72%
cases:23.46%
controls:10.25%
cases:34.16%
controls:13.84%
91
411
149
1850
67
292
184
2069
17
61
234
2300
—
18
64
233
2290
57
234
186
2048
69
264
133
1644
Clinical photography of mouth and teeth
SBB00 [2001310298]
1.4e+00
1.6e+00
—
1.0e+50
—
2.0e+00
1.2e+00
cases:7.50%
controls:1.99%
cases:3.59%
controls:0.76%
—
—
cases:3.19%
controls:0.00%
—
—
cases:6.58%
controls:0.96%
cases:11.88%
controls:3.93%
18
45
222
2216
9
18
242
2343
—
8
0
243
2361
—
16
22
227
2260
24
75
178
1833
X-ray examination of the lungs in one projection
GD1PA [2001303645]
9.9e-01
1.5e+00
—
—
—
2.0e+00
1.6e+00
cases:10.42%
controls:4.16%
cases:4.78%
controls:1.06%
—
—
—
—
—
—
cases:4.53%
controls:0.61%
cases:5.45%
controls:1.21%
25
94
215
2167
12
25
239
2336
—
—
—
11
14
232
2268
11
23
191
1885
Left side
ZXA05 [2001311347]
1.4e+00
2.5e+00
—
—
—
—
2.2e+00
cases:9.17%
controls:2.34%
cases:4.78%
controls:0.42%
—
—
—
—
—
—
—
—
cases:6.93%
controls:0.84%
22
53
218
2208
12
10
239
2351
—
—
—
—
14
16
188
1892
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
7.4e-01
1.8e+00
—
—
—
2.0e+00
2.1e+00
cases:2.92%
controls:1.42%
cases:3.59%
controls:0.59%
—
—
—
—
—
—
cases:4.12%
controls:0.57%
cases:8.42%
controls:1.10%
7
32
233
2229
9
14
242
2347
—
—
—
10
13
233
2269
17
21
185
1887
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
-3.6e-02
1.3e+00
—
—
2.3e+00
1.2e+00
1.1e+00
cases:5.00%
controls:5.17%
cases:5.98%
controls:1.65%
—
—
—
—
cases:2.39%
controls:0.25%
cases:7.00%
controls:2.15%
cases:15.35%
controls:5.71%
12
117
228
2144
15
39
236
2322
—
—
6
6
245
2348
17
49
226
2233
31
109
171
1799
Bacteria identified in Urine by Culture
630-4 [3026008]
1.0e+00
1.6e+00
—
—
—
1.6e+00
1.7e+00
cases:12.92%
controls:5.00%
cases:7.57%
controls:1.69%
—
—
—
—
—
—
cases:7.41%
controls:1.67%
cases:16.83%
controls:3.41%
31
113
209
2148
19
40
232
2321
—
—
—
18
38
225
2244
34
65
168
1843
Physical Medicine And Rehabilitation
25 [38004468]
1.2e+00
1.5e+00
2.0e+00
—
—
1.2e+00
7.6e-01
cases:10.83%
controls:3.54%
cases:7.97%
controls:1.95%
cases:2.79%
controls:0.38%
—
—
—
—
cases:6.17%
controls:1.93%
cases:11.88%
controls:5.92%
26
80
214
2181
20
46
231
2315
7
9
244
2352
—
—
15
44
228
2238
24
113
178
1795
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.1e+00
1.9e+00
—
—
—
1.8e+00
1.0e+00
cases:11.67%
controls:4.16%
cases:9.16%
controls:1.48%
—
—
—
—
—
—
cases:5.76%
controls:1.01%
cases:8.91%
controls:3.35%
28
94
212
2167
23
35
228
2326
—
—
—
14
23
229
2259
18
64
184
1844
Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
33941-6 [3029493]
2.9e+00
2.9e+00
—
—
—
—
1.0e+50
cases:5.42%
controls:0.31%
cases:5.18%
controls:0.30%
—
—
—
—
—
—
—
—
cases:7.92%
controls:0.00%
13
7
227
2254
13
7
238
2354
—
—
—
—
16
0
186
1908
Kidney Pathology biopsy report
65757-7 [40768446]
2.8e+00
—
—
—
—
—
3.0e+00
cases:5.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:4.95%
controls:0.26%
12
7
228
2254
—
—
—
—
—
10
5
192
1903
Child-centred family therapy
IEP02 [2001304194]
1.9e+00
1.9e+00
—
—
—
2.0e+00
1.2e+00
cases:5.00%
controls:0.80%
cases:3.98%
controls:0.64%
—
—
—
—
—
—
cases:2.88%
controls:0.39%
cases:5.45%
controls:1.68%
12
18
228
2243
10
15
241
2346
—
—
—
7
9
236
2273
11
32
191
1876
Nutritional therapy
R4190 [2001310243]
1.5e+00
1.4e+00
—
—
2.3e+00
1.7e+00
1.2e+00
cases:13.33%
controls:3.45%
cases:8.76%
controls:2.33%
—
—
—
—
cases:1.99%
controls:0.21%
cases:7.82%
controls:1.49%
cases:8.91%
controls:2.99%
32
78
208
2183
22
55
229
2306
—
—
5
5
246
2349
19
34
224
2248
18
57
184
1851
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
1.6e+00
1.7e+00
—
—
—
1.2e+00
2.3e+00
cases:10.42%
controls:2.34%
cases:5.98%
controls:1.10%
—
—
—
—
—
—
cases:2.47%
controls:0.79%
cases:7.43%
controls:0.79%
25
53
215
2208
15
26
236
2335
—
—
—
6
18
237
2264
15
15
187
1893
Examination of eyes and vision
Z01.0 [45566391]
1.4e+00
1.4e+00
—
—
—
1.4e+00
1.4e+00
cases:23.33%
controls:6.77%
cases:8.76%
controls:2.41%
—
—
—
—
—
—
cases:7.82%
controls:1.97%
cases:17.82%
controls:5.08%
56
153
184
2108
22
57
229
2304
—
—
—
19
45
224
2237
36
97
166
1811
cefalexin; oral
J01DB01 [21602870]
1.0e+00
1.1e+00
1.5e+00
—
1.2e+00
9.0e-01
1.1e+00
cases:50.83%
controls:27.55%
cases:22.31%
controls:8.64%
cases:4.38%
controls:0.97%
—
—
cases:2.79%
controls:0.85%
cases:18.52%
controls:8.46%
cases:45.05%
controls:22.27%
122
623
118
1638
56
204
195
2157
11
23
240
2338
—
7
20
244
2334
45
193
198
2089
91
425
111
1483
Oxygen content in Venous blood
19220-3 [3011648]
2.1e+00
3.0e+00
—
—
—
—
2.6e+00
cases:2.08%
controls:0.27%
cases:3.98%
controls:0.21%
—
—
—
—
—
—
—
—
cases:3.47%
controls:0.26%
5
6
235
2255
10
5
241
2356
—
—
—
—
7
5
195
1903
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
9.1e-01
1.8e+00
—
—
—
2.2e+00
1.6e+00
cases:6.67%
controls:2.79%
cases:5.98%
controls:1.06%
—
—
—
—
—
—
cases:4.94%
controls:0.57%
cases:8.42%
controls:1.83%
16
63
224
2198
15
25
236
2336
—
—
—
12
13
231
2269
17
35
185
1873
methotrexate; oral, parenteral
L04AX03 [21603929]
1.9e+00
1.9e+00
1.8e+00
—
2.1e+00
1.5e+00
1.3e+00
cases:8.75%
controls:1.46%
cases:6.77%
controls:1.06%
cases:3.19%
controls:0.55%
—
—
cases:1.99%
controls:0.25%
cases:3.70%
controls:0.88%
cases:3.47%
controls:1.00%
21
33
219
2228
17
25
234
2336
8
13
243
2348
—
5
6
246
2348
9
20
234
2262
7
19
195
1889
methotrexate
L01BA01 [21601423]
1.9e+00
1.9e+00
1.8e+00
—
2.1e+00
1.5e+00
1.3e+00
cases:8.75%
controls:1.46%
cases:6.77%
controls:1.06%
cases:3.19%
controls:0.55%
—
—
cases:1.99%
controls:0.25%
cases:3.70%
controls:0.88%
cases:3.47%
controls:1.00%
21
33
219
2228
17
25
234
2336
8
13
243
2348
—
5
6
246
2348
9
20
234
2262
7
19
195
1889
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
1.3e+00
1.5e+00
—
1.0e+50
—
1.9e+00
2.7e+00
cases:7.08%
controls:2.03%
cases:4.38%
controls:0.97%
—
—
cases:1.99%
controls:0.00%
—
—
cases:2.06%
controls:0.31%
cases:4.46%
controls:0.31%
17
46
223
2215
11
23
240
2338
—
5
0
246
2361
—
5
7
238
2275
9
6
193
1902
Extensive MRI examination of abdomen with high intensity magnet
JN3CG [2001305563]
2.9e+00
—
—
—
—
—
2.6e+00
cases:4.58%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:3.47%
controls:0.26%
11
6
229
2255
—
—
—
—
—
7
5
195
1903
More than five and less than seven hours
ZXE30 [2001311411]
1.5e+00
2.3e+00
—
—
—
—
1.7e+00
cases:6.25%
controls:1.46%
cases:3.19%
controls:0.34%
—
—
—
—
—
—
—
—
cases:3.96%
controls:0.73%
15
33
225
2228
8
8
243
2353
—
—
—
—
8
14
194
1894
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
2.7e+00
—
—
—
—
—
2.8e+00
cases:3.75%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:3.96%
controls:0.26%
9
6
231
2255
—
—
—
—
—
8
5
194
1903
sodium fluoride; oral
A01AA01 [21600005]
2.4e+00
—
—
—
—
—
3.0e+00
cases:3.33%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:5.94%
controls:0.31%
8
7
232
2254
—
—
—
—
—
12
6
190
1902
Lumbar puncture
TAB00 [2001300538]
2.4e+00
2.9e+00
—
—
1.0e+50
—
—
cases:10.00%
controls:0.97%
cases:6.37%
controls:0.38%
—
—
—
—
cases:2.39%
controls:0.00%
—
—
—
—
24
22
216
2239
16
9
235
2352
—
—
6
0
245
2354
—
—
sodium chloride; oral
A12CA01 [21600886]
2.6e+00
2.6e+00
—
—
—
—
—
cases:4.17%
controls:0.31%
cases:2.79%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
10
7
230
2254
7
5
244
2356
—
—
—
—
—
Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
47255-5 [3049714]
2.6e+00
—
—
—
—
—
2.6e+00
cases:2.92%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:3.47%
controls:0.26%
7
5
233
2256
—
—
—
—
—
7
5
195
1903
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
1.8e+00
8.7e-01
—
—
—
1.6e+00
1.7e+00
cases:9.17%
controls:1.59%
cases:1.99%
controls:0.85%
—
—
—
—
—
—
cases:3.29%
controls:0.66%
cases:7.92%
controls:1.57%
22
36
218
2225
5
20
246
2341
—
—
—
8
15
235
2267
16
30
186
1878
Other reactions to severe stress
F43.8 [45552483]
2.4e+00
—
—
—
—
—
2.7e+00
cases:2.50%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:4.46%
controls:0.31%
6
5
234
2256
—
—
—
—
—
9
6
193
1902
Flexible bronchoscopy
UGC12 [2001303610]
2.0e+00
—
—
—
—
—
3.1e+00
cases:3.33%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
cases:5.45%
controls:0.26%
8
10
232
2251
—
—
—
—
—
11
5
191
1903
Infiltration anesthesia
WX110 [2001310767]
7.4e-01
1.2e+00
1.5e+00
1.0e+50
1.6e+00
8.6e-01
7.6e-01
cases:36.25%
controls:21.41%
cases:21.51%
controls:7.96%
cases:2.39%
controls:0.55%
cases:3.98%
controls:0.00%
cases:5.58%
controls:1.15%
cases:17.28%
controls:8.15%
cases:48.51%
controls:30.61%
87
484
153
1777
54
188
197
2173
6
13
245
2348
10
0
241
2361
14
27
237
2327
42
186
201
2096
98
584
104
1324
CBC panel - Blood by Automated count
58410-2 [40761511]
3.1e-01
7.6e-01
1.3e+00
—
1.7e+00
6.1e-01
7.6e-01
cases:38.75%
controls:31.80%
cases:28.29%
controls:15.59%
cases:7.57%
controls:2.24%
—
—
cases:9.56%
controls:1.87%
cases:20.99%
controls:12.62%
cases:45.05%
controls:27.78%
93
719
147
1542
71
368
180
1993
19
53
232
2308
—
24
44
227
2310
51
288
192
1994
91
530
111
1378
Other specified special examinations
Z01.8 [45581003]
9.5e-01
1.4e+00
—
—
—
1.8e+00
9.9e-01
cases:12.08%
controls:5.04%
cases:6.77%
controls:1.82%
—
—
—
—
—
—
cases:6.17%
controls:1.10%
cases:10.89%
controls:4.35%
29
114
211
2147
17
43
234
2318
—
—
—
15
25
228
2257
22
83
180
1825
Bilateral
ZXA10 [2001311348]
1.5e+00
1.4e+00
—
—
—
1.5e+00
2.1e+00
cases:17.08%
controls:4.20%
cases:3.98%
controls:1.02%
—
—
—
—
—
—
cases:2.06%
controls:0.48%
cases:7.43%
controls:1.00%
41
95
199
2166
10
24
241
2337
—
—
—
5
11
238
2271
15
19
187
1889
Basic examination of mouth
SAA02 [2001310275]
9.9e-01
1.0e+00
—
—
2.0e+00
9.7e-01
1.8e-01
cases:56.67%
controls:32.73%
cases:31.47%
controls:14.44%
—
—
—
—
cases:7.17%
controls:1.02%
cases:31.69%
controls:14.90%
cases:60.89%
controls:56.45%
136
740
104
1521
79
341
172
2020
—
—
18
24
233
2330
77
340
166
1942
123
1077
79
831
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
1.1e+00
2.9e+00
—
—
—
2.1e+00
2.1e+00
cases:2.50%
controls:0.84%
cases:3.59%
controls:0.21%
—
—
—
—
—
—
cases:2.06%
controls:0.26%
cases:6.44%
controls:0.84%
6
19
234
2242
9
5
242
2356
—
—
—
5
6
238
2276
13
16
189
1892
Case Management Agency
251B00000X [38004193]
7.7e-01
1.9e-01
2.6e-01
3.5e+00
5.8e-01
1.8e-01
7.1e-01
cases:87.50%
controls:76.47%
cases:79.28%
controls:76.07%
cases:39.84%
controls:33.88%
cases:39.84%
controls:1.91%
cases:47.01%
controls:33.22%
cases:82.30%
controls:79.45%
cases:98.51%
controls:97.01%
210
1729
30
532
199
1796
52
565
100
800
151
1561
100
45
151
2316
118
782
133
1572
200
1813
43
469
199
1851
3
57
oseltamivir; oral
J05AH02 [21603179]
1.2e+00
—
—
—
—
2.4e+00
2.5e+00
cases:4.17%
controls:1.24%
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.35%
cases:6.44%
controls:0.58%
10
28
230
2233
—
—
—
—
9
8
234
2274
13
11
189
1897
Fissure sealant
SCE00 [2001310316]
1.3e+00
1.0e+00
—
1.0e+50
—
2.1e+00
1.5e+00
cases:14.58%
controls:4.47%
cases:4.78%
controls:1.74%
—
—
cases:6.77%
controls:0.00%
—
—
cases:12.35%
controls:1.75%
cases:28.22%
controls:8.12%
35
101
205
2160
12
41
239
2320
—
17
0
234
2361
—
30
40
213
2242
57
155
145
1753
sodium chloride
B05XA03 [21601198]
2.4e+00
2.4e+00
—
—
—
—
—
cases:3.33%
controls:0.31%
cases:2.39%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
8
7
232
2254
6
5
245
2356
—
—
—
—
—
budesonide; oral, sublingual
A07EA06 [21600658]
2.4e+00
2.4e+00
—
—
—
—
2.0e+00
cases:4.58%
controls:0.44%
cases:2.39%
controls:0.21%
—
—
—
—
—
—
—
—
cases:2.97%
controls:0.42%
11
10
229
2251
6
5
245
2356
—
—
—
—
6
8
196
1900
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
2.4e+00
—
—
—
—
2.4e+00
1.8e+00
cases:5.00%
controls:0.49%
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.22%
cases:2.97%
controls:0.52%
12
11
228
2250
—
—
—
—
6
5
237
2277
6
10
196
1898

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
81
19
56.49
138.24
40.3
46.8
139.64
107.42
ug/l
1.09
72
19
113
101
16.71
113.62
4.3
3.2
13.18
25.60
mu/l
1.69
113
93
180
329
11.28
107.60
10.2
2.6
21.68
21.38
%
0.12
180
321
114
122
13.93
101.61
4.5
1.6
102.50
98.02
au/ml
0.13
63
46
187
394
10.08
97.34
10.2
2.6
13.01
14.19
umol/l
1.57
187
385
113
127
13.18
97.14
4.5
1.6
—
—
—
0
0
97
86
15.69
97.14
2.6
1.4
—
—
—
0
0
161
287
10.30
96.93
7.3
3.3
60.34
63.44
e9/l
0.43
122
156
188
414
9.65
93.38
43.8
7.6
7.84
4.77
mmol/l
14.39
188
407
119
161
11.15
88.83
12.2
8.2
226.45
313.38
mg/l
0.78
109
127
120
194
9.28
76.62
4.0
1.6
192.27
137.29
u/ml
1.03
81
72
54
23
27.87
76.13
3.3
1.8
—
—
—
0
0
181
490
7.23
69.74
18.0
3.4
7.38
7.38
ph
0.83
137
322
141
301
7.58
69.06
22.0
4.5
7.54
5.89
umol/l
0.36
127
239
214
698
7.32
67.01
36.8
7.6
—
—
—
0
0
185
570
6.35
60.16
9.9
3.0
602.45
601.15
mosm/kgh2o
0.02
178
493
211
766
6.21
55.84
33.5
5.3
5.30
5.14
kpa
0.63
211
754
214
791
6.21
55.31
36.1
5.5
5.74
5.84
kpa
1.37
214
775
213
787
6.16
54.99
36.0
5.5
1.02
1.10
mmol/l
0.20
199
639
213
790
6.13
54.65
37.0
5.6
7.37
7.37
ph
1.98
195
533
192
653
5.88
54.52
8.8
2.5
—
—
—
0
0
179
575
5.81
54.31
10.2
3.3
0.49
0.72
e6/l
0.95
135
300
182
594
5.81
54.17
12.9
3.0
4.11
6.52
e6/l
2.58
174
522
47
32
16.93
53.39
1.6
1.4
—
—
—
0
0
144
393
5.84
52.46
11.0
3.5
—
—
—
0
0
67
83
9.89
51.90
6.1
2.5
1144.98
1629.39
e6/l
1.89
47
61
135
353
5.87
51.49
10.7
3.5
2.95
2.10
mg/l
0.32
119
242
54
50
12.71
51.30
2.6
1.5
—
—
—
0
0
65
79
10.01
51.05
6.1
2.7
0.21
0.41
e9/l
2.82
42
55
176
584
5.49
50.63
10.2
3.4
2.03
1.58
e6/l
0.30
132
313
54
54
11.75
48.69
4.6
4.4
20.93
24.35
umol/l
1.89
54
54
216
872
5.60
48.26
16.2
3.7
0.16
0.18
e6/l
0.08
182
621
52
8
76.71
46.61
4.2
3.0
—
—
—
0
0
135
382
5.37
46.33
3.9
1.5
—
—
—
0
0
275
1394
8.37
46.04
35.2
7.5
—
—
—
0
0
62
81
9.20
45.84
3.3
1.8
—
—
—
0
0
62
81
9.20
45.84
3.3
1.8
—
—
—
0
0
62
81
9.20
45.84
3.3
1.8
—
—
—
0
0
62
81
9.20
45.84
3.3
1.8
—
—
—
0
0
247
1156
6.12
44.87
26.3
6.2
—
—
—
0
0
205
833
5.10
44.28
8.4
2.9
—
—
estimate
—
0
0
220
947
5.29
44.07
18.2
3.8
12.21
24.44
e6/l
1.91
189
693
108
264
5.64
43.62
35.1
8.9
105.52
105.41
mmol/l
0.09
108
264
156
518
4.92
43.53
11.8
4.4
1.24
1.20
inr
0.12
131
421
60
81
8.83
43.11
6.1
2.5
449.46
549.36
e6/l
0.62
39
59
40
30
14.99
42.89
17.1
5.2
6.03
4.36
pmol/l
1.15
40
30
60
82
8.72
42.66
6.1
2.5
129.00
230.38
e6/l
2.50
39
60
60
83
8.61
42.22
5.3
3.5
4.05
14.61
index
1.34
41
46
77
142
6.79
41.75
2.4
1.7
20.13
22.56
ng/l
0.55
77
142
90
195
6.00
41.33
3.5
1.9
—
—
—
0
0
99
235
5.63
41.11
16.6
5.7
2291.33
1144.06
ng/l
0.95
92
195
235
1110
5.29
40.60
23.3
4.7
13.08
36.46
e6/l
2.64
190
716
95
224
5.58
39.62
3.3
2.0
—
—
—
0
0
167
620
4.54
39.50
2.9
1.9
1.21
1.14
mmol/l
0.56
167
585
70
124
6.90
39.35
31.3
6.8
0.55
0.67
%
1.82
70
124
182
733
4.45
38.24
28.2
7.2
7.41
7.41
ph
0.30
171
573
264
1408
6.22
38.07
59.4
9.1
1.22
1.22
mmol/l
0.16
259
1329
167
646
4.31
36.76
27.3
7.0
—
—
—
0
0
94
242
5.06
35.04
3.8
2.4
7.90
7.76
iu/l
0.03
63
136
98
262
4.93
34.88
3.7
2.4
4.89
4.53
u/l
0.16
67
136
67
129
6.27
34.45
9.7
6.1
0.44
0.33
%
0.30
43
42
258
1427
5.32
33.38
34.6
6.3
5.68
6.19
mmol/l
6.48
253
1352
36
34
11.72
33.37
6.3
4.7
0.53
0.71
index
0.50
36
34
69
143
5.84
32.77
11.0
6.2
0.37
0.29
%
0.21
46
45
52
81
7.42
32.72
38.2
8.5
74.48
71.78
%
0.50
52
81
287
1748
7.84
32.49
40.4
7.7
0.03
0.04
e9/l
2.36
262
1406
287
1755
7.77
32.13
40.4
7.6
0.59
0.55
e9/l
1.85
262
1412
39
45
9.66
31.38
15.8
4.0
—
—
—
0
0
39
45
9.66
31.38
6.0
1.8
0.93
1.07
g/l
0.44
39
39
50
78
7.36
31.38
37.4
9.7
74.15
70.80
%
0.66
50
78
288
1789
7.73
31.01
45.3
8.1
0.21
0.23
e9/l
0.82
267
1482
106
328
4.32
30.89
3.4
1.7
—
—
—
0
0
134
491
3.96
30.80
6.0
2.4
—
—
—
0
0
278
1687
6.27
30.48
44.4
8.6
0.00
0.01
e9/l
0.46
245
1243
287
1791
7.42
30.34
40.4
7.6
2.17
2.33
e9/l
1.73
267
1496
43
60
8.07
29.70
3.1
1.4
—
—
—
0
0
171
752
3.73
29.66
4.5
3.8
2.86
2.28
mg/l
2.43
159
669
66
146
5.40
29.00
11.1
6.2
0.05
0.00
%
0.80
40
40
288
1845
7.18
28.33
48.1
8.4
3.18
3.39
e9/l
0.78
264
1488
198
982
3.68
28.00
12.0
2.9
6.31
6.32
ph
0.05
73
440
40
55
8.11
27.93
41.1
10.1
11.20
12.23
%
1.11
40
55
57
114
5.83
27.91
37.6
16.7
23.03
23.62
mmol/l
0.75
57
114
34
40
9.32
26.86
15.2
7.7
7.39
7.39
ph
0.03
34
40
34
42
8.87
25.85
6.3
3.7
3.23
2.85
e9/l
0.55
34
42
41
64
7.15
25.57
21.4
7.2
1.24
1.23
mmol/l
0.18
41
53
94
304
3.94
25.23
2.7
1.6
—
—
—
0
0
60
138
5.09
25.04
11.9
6.3
0.03
0.00
%
0.49
38
39
61
144
4.97
24.67
36.7
17.4
-1.53
-0.34
mmol/l
1.46
56
120
61
144
4.97
24.67
36.8
17.5
7.42
7.38
ph
1.44
15
44
38
57
7.38
24.54
5.6
1.9
0.58
1.03
e9/l
2.80
38
57
116
447
3.49
23.74
2.4
1.7
—
—
—
0
0
51
107
5.44
23.57
42.0
18.1
95.03
95.47
%
0.16
51
107
51
107
5.44
23.57
41.7
18.1
1.00
1.00
%
0.00
51
107
31
11
30.79
23.55
1.0
1.0
—
—
—
0
0
31
11
30.79
23.55
1.0
1.2
—
—
—
0
0
50
104
5.47
23.32
42.7
18.5
0.67
0.68
%
0.01
50
104
27
28
10.36
23.31
17.3
9.8
0.80
2.05
mmol/l
1.22
13
13
27
28
10.36
23.31
17.3
9.9
10.94
8.46
kpa
3.38
27
28
27
28
10.36
23.31
17.3
9.8
4.79
4.84
kpa
0.13
27
28
27
29
10.00
22.73
1.1
1.4
—
—
—
0
0
27
29
10.00
22.73
1.1
1.4
—
—
—
0
0
27
29
10.00
22.73
2.1
1.8
—
—
—
0
0
209
1166
3.30
22.59
14.4
3.2
0.00
0.00
estimate
-0.00
45
164
238
1451
3.54
21.82
17.1
3.4
78.36
148.57
e6/l
0.26
11
14
205
1150
3.18
21.57
14.6
3.1
0.00
0.00
estimate
-0.00
45
169
206
1161
3.18
21.45
14.6
3.1
27.33
0.00
estimate
0.49
45
163
43
85
5.65
21.13
1.2
1.2
—
—
—
0
0
71
224
3.76
19.34
3.3
2.1
40.48
29.17
u/l
0.77
61
181
91
349
3.23
18.17
2.4
1.5
208.89
674.78
titre
2.97
18
46
28
42
7.16
17.97
2.1
3.2
15.08
16.57
umol/l
0.19
28
42
17
0
+∞
17.82
3.5
0.0
0.58
—
mmol/l
—
17
0
307
2505
8.55
17.78
62.9
8.2
73.51
55.96
umol/l
4.16
307
2460
30
50
6.47
17.45
5.7
4.4
4.05
11.28
u/ml
0.48
30
50
50
133
4.24
17.17
10.8
3.0
0.08
0.25
e6/l
0.65
50
128
105
451
2.96
17.09
2.6
1.8
—
—
—
0
0
81
304
3.21
16.64
7.3
2.9
798.56
1313.70
ng/l
0.53
57
180
28
46
6.52
16.50
1.6
3.5
26.04
43.07
mmol/l
2.46
28
46
66
225
3.41
15.79
3.5
2.2
8.60
8.47
nmol/l
0.04
58
199
18
5
37.69
14.54
1.9
1.0
5.81
—
pmol/l
—
13
0
74
284
3.07
14.47
7.8
4.4
167.53
92.40
mg/l
0.73
65
239
218
1477
2.49
12.68
4.8
2.4
5.25
5.41
mmol/l
2.92
213
1345
48
153
3.49
12.63
1.3
1.2
—
—
—
0
0
19
11
18.11
12.61
6.3
6.0
200.32
244.91
ug/l
0.29
19
11
107
530
2.51
12.61
2.4
1.7
102.19
96.26
pmol/l
0.69
58
253
117
606
2.45
12.50
2.7
2.3
—
—
—
0
0
20
14
15.03
12.38
7.5
3.0
-0.90
-0.84
mmol/l
—
15
9
136
782
2.27
11.17
1.9
1.5
—
—
—
0
0
66
273
2.77
11.07
9.2
4.7
22.50
7.36
mg/mmol
1.75
58
225
30
76
4.22
10.88
1.4
1.5
1348.04
1140.20
nmol/l
0.51
24
56
16
10
16.62
10.41
11.7
4.9
—
—
—
0
0
93
467
2.38
10.36
22.6
4.2
—
—
—
0
0
21
25
8.84
10.16
1.6
1.5
—
—
—
0
0
20
22
9.54
10.11
2.6
1.8
—
—
—
0
0
32
90
3.81
10.08
1.7
1.2
—
—
—
0
0
34
101
3.62
9.90
1.7
1.4
—
—
—
0
0
18
17
11.05
9.86
3.2
2.4
—
—
—
0
0
47
174
2.97
9.60
1.9
1.3
—
—
—
0
0
20
40
5.22
9.59
1.4
1.7
2.33
6.08
u/ml
1.19
12
25
15
11
14.12
9.22
2.7
1.5
32.33
32.36
pg
0.01
15
11
20
27
7.76
9.02
1.7
1.5
1.25
1.02
iu/ml
0.23
12
16
38
130
3.16
8.87
2.6
1.4
0.22
0.19
g/l
0.70
38
125
38
132
3.11
8.65
2.6
1.4
1.01
1.14
g/l
1.67
38
126
20
31
6.75
8.27
1.1
1.4
—
—
—
0
0
18
24
7.82
8.23
1.4
1.7
0.34
0.23
iu/ml
—
10
18
60
273
2.46
8.16
4.3
1.9
87.51
17.03
ng/l
1.12
39
107
11
5
22.51
8.03
3.0
2.4
1268.36
1054.40
mg
—
11
5
39
144
2.92
7.98
7.2
2.1
49.53
53.28
%
0.94
39
144
27
80
3.57
7.88
10.2
3.8
—
—
—
0
0
32
106
3.22
7.87
7.8
2.1
37.62
29.48
umol/l
1.61
32
100
16
19
8.73
7.86
1.8
3.8
1.10
1.04
umol/l
0.32
16
19
23
61
3.95
7.84
1.4
1.2
—
—
—
0
0
18
26
7.21
7.84
1.4
1.3
100.72
127.19
pmol/l
1.02
18
26
18
27
6.94
7.65
1.1
1.1
—
—
—
0
0
23
63
3.83
7.51
7.6
2.4
—
—
—
0
0
12
9
13.68
7.40
1.6
1.1
—
—
—
0
0
10
5
20.40
7.14
2.5
2.2
—
—
—
0
0
36
136
2.83
7.06
1.6
1.6
—
—
—
0
0
29
97
3.16
7.02
11.0
2.6
—
—
—
0
0
15
20
7.75
6.94
1.3
1.5
—
—
—
0
0
24
73
3.45
6.74
3.0
1.5
19.32
6.86
ug/l
1.10
17
58
43
183
2.54
6.70
1.8
1.5
—
—
—
0
0
294
2544
3.09
6.64
32.4
7.1
—
—
—
0
0
29
101
3.03
6.56
11.2
2.6
503.05
336.51
e6/l
0.14
21
72
177
1281
1.84
6.53
3.1
1.8
1.56
1.50
g/l
0.21
128
584
34
130
2.79
6.52
15.6
2.7
—
—
—
0
0
24
75
3.35
6.47
3.5
2.8
—
—
—
0
0
29
102
3.00
6.46
11.2
2.5
6.14
14.67
e6/l
0.47
21
72
43
188
2.47
6.33
2.5
1.6
—
—
—
0
0
9
5
18.31
6.27
5.3
2.0
162.56
177.60
e6/l
—
9
5
16
28
5.91
6.18
5.1
3.2
3.51
1.62
%
—
8
9
10
8
12.74
6.09
18.8
17.0
—
—
—
0
0
22
69
3.32
5.90
1.5
1.4
342.92
369.49
ug/g
0.21
13
39
16
31
5.33
5.74
5.7
18.9
—
—
—
0
0
28
104
2.83
5.67
11.5
2.6
555.29
372.13
mg/l
0.25
28
104
12
16
7.68
5.65
2.1
4.7
13.43
24.18
mg/l
—
6
10
25
89
2.94
5.46
12.7
2.8
—
—
—
0
0
15
29
5.33
5.42
2.5
3.1
—
—
—
0
0
11
15
7.49
5.15
1.3
1.7
—
—
—
0
0
11
15
7.49
5.15
1.3
1.7
—
—
—
0
0
11
15
7.49
5.15
1.3
1.7
—
—
—
0
0
15
40
3.85
5.08
1.4
1.0
—
—
—
0
0
9
10
9.14
4.78
1.0
1.1
—
—
—
0
0
8
7
11.58
4.78
1.3
1.6
—
—
—
0
0
11
17
6.60
4.78
12.9
4.4
5.30
4.92
kpa
0.75
11
17
12
21
5.84
4.76
2.0
2.3
1383.17
1342.00
u/ml
0.03
12
21
7
5
14.15
4.57
3.0
2.4
106.71
106.60
mmol/l
—
7
5
7
5
14.15
4.57
3.0
2.4
1.26
1.22
mmol/l
—
7
5
296
2657
2.65
4.57
61.3
9.6
21.67
24.94
mg/l
1.39
266
1813
16
50
3.29
4.33
1.3
1.2
—
—
—
0
0
11
20
5.61
4.29
1.9
1.4
—
—
—
0
0
7
6
11.79
4.27
3.0
2.2
4.59
3.85
mmol/l
—
7
6
7
6
11.79
4.27
1.3
1.3
—
—
—
0
0
29
129
2.35
4.12
2.8
2.2
0.00
0.00
estimate
-0.00
11
33
10
18
5.65
3.98
1.5
1.6
15.73
15.69
umol/l
—
10
18
10
18
5.65
3.98
5.5
4.3
—
132.88
—
0
8
79
514
1.70
3.81
18.4
3.1
0.00
0.00
estimate
-0.00
41
163
7
8
8.84
3.77
1.3
1.1
142.43
119.75
nmol/l
—
7
8
6
5
12.09
3.76
2.7
2.2
4.50
1.74
mg/l
—
6
5
13
35
3.79
3.60
10.3
4.5
31.89
23.66
ug/l
0.52
13
35
10
21
4.84
3.55
3.6
1.7
—
—
—
0
0
7
10
7.07
3.36
1.9
2.4
49.43
24.10
u/l
—
7
10
9
19
4.80
3.23
1.4
2.0
2053.33
1418.68
ml
—
9
19
18
74
2.50
3.05
1.7
1.1
—
—
—
0
0
35
191
1.92
3.00
2.7
1.8
—
—
—
0
0
5
5
10.04
2.97
6.4
24.8
13.72
13.28
ml/dl
—
5
5
73
500
1.58
2.82
16.3
2.5
0.00
0.00
estimate
-0.00
38
133
5
6
8.37
2.74
2.4
2.7
14.20
6.67
%
—
5
6
5
6
8.37
2.74
1.2
1.3
15.00
39.83
%
—
5
6
9
24
3.79
2.67
5.3
5.0
1.70
1.40
mmol/l
—
9
24
7
15
4.71
2.59
3.3
2.2
97.14
98.40
g/l
—
7
15
7
15
4.71
2.59
2.6
1.9
—
—
—
0
0
14
57
2.50
2.44
3.2
2.6
0.00
0.00
estimate
—
7
29
88
647
1.48
2.44
4.6
3.7
201.38
77.06
ug/g
0.88
81
536
9
29
3.14
2.22
1.0
1.0
—
—
—
0
0
5
9
5.57
2.20
1.4
1.9
—
—
—
0
0
5
9
5.57
2.20
1.4
1.8
—
—
—
0
0
6
14
4.31
2.14
1.7
1.0
469.83
43.71
pmol/l
—
6
14
95
730
1.42
2.05
16.8
2.7
0.00
0.01
estimate
0.50
42
133
7
20
3.52
2.05
2.4
2.2
7.84
6.92
ug/l
—
7
20
11
44
2.53
2.00
1.4
1.0
1.47
1.36
g/l
0.59
11
44
58
410
1.49
1.93
1.9
2.0
—
—
—
0
0
6
16
3.77
1.93
1.2
1.1
—
—
—
0
0
6
16
3.77
1.93
1.2
1.1
—
760.00
—
0
5
9
33
2.75
1.92
1.2
1.1
—
—
—
0
0
42
278
1.57
1.88
4.5
2.5
—
—
—
0
0
5
13
3.86
1.71
6.2
2.5
4.70
4.48
mmol/l
—
5
13
6
20
3.01
1.57
1.2
1.2
71.67
75.70
%
—
6
20
6
20
3.01
1.57
1.2
1.2
384.50
461.85
mu/l
—
6
20
7
27
2.60
1.50
1.3
1.4
9.69
7.97
umol/l
—
7
27
55
412
1.39
1.36
3.5
1.9
—
—
—
0
0
72
568
1.33
1.29
13.3
2.6
1.02
1.02
kg/l
1.30
55
364
5
18
2.78
1.27
1.0
1.5
—
—
—
0
0
5
19
2.63
1.21
3.4
2.9
24.26
19.17
umol/l
—
5
19
6
26
2.31
1.18
1.0
1.5
5829.00
8587.95
e6/l
—
6
19
8
39
2.06
1.15
1.3
1.1
—
—
—
0
0
5
20
2.50
1.14
1.0
1.0
—
—
—
0
0
8
40
2.01
1.11
1.0
1.3
—
40.14
—
0
12
7
31
2.27
1.10
5.6
2.5
13.96
28.92
mg/l
—
7
19
5
21
2.38
1.08
1.0
1.1
—
—
—
0
0
9
46
1.97
1.04
1.0
1.0
162.00
164.35
g/l
—
9
46
9
47
1.92
1.02
3.1
1.0
0.76
0.81
g/l
—
9
47
17
108
1.59
0.95
1.4
1.2
—
—
—
0
0
14
217
0.62
0.94
1.0
1.1
0.03
1.23
u/ml
—
9
125
13
78
1.68
0.90
10.4
3.2
2.80
1.48
ug/l
0.32
13
65
14
87
1.62
0.86
4.9
6.2
2.15
2.10
ug/l
0.03
14
87
24
324
0.71
0.83
1.8
2.0
—
—
—
0
0
24
322
0.72
0.80
1.8
2.0
—
—
—
0
0
24
321
0.72
0.79
1.8
2.0
—
—
—
0
0
36
278
1.32
0.78
1.4
1.2
10.60
22.75
iu/ml
—
10
47
24
319
0.73
0.76
1.8
2.0
—
—
—
0
0
23
306
0.73
0.74
1.8
2.0
—
—
—
0
0
18
245
0.71
0.67
1.0
1.3
10.08
151.91
u/ml
—
5
58
24
180
1.35
0.64
1.3
1.1
—
12.18
—
0
15
5
30
1.66
0.61
1.4
1.0
—
—
—
0
0
5
30
1.66
0.61
1.2
1.1
120.00
208.88
mg/l
—
5
30
0
21
0.00
0.60
0.0
1.0
—
16.27
—
0
16
26
200
1.31
0.60
3.6
2.3
169.53
5049.90
u/l
—
7
54
6
35
1.71
0.57
1.2
1.2
—
—
—
0
0
9
62
1.45
0.53
1.4
1.6
—
—
—
0
0
27
214
1.27
0.51
2.4
1.5
—
—
—
0
0
9
64
1.41
0.51
1.6
1.7
—
—
—
0
0
9
64
1.41
0.51
2.2
1.5
—
—
—
0
0
76
671
1.16
0.51
1.3
1.3
—
—
—
0
0
17
126
1.36
0.50
1.4
1.2
—
—
—
0
0
15
109
1.38
0.50
1.4
1.6
0.16
0.21
mg/l
—
6
43
17
127
1.35
0.48
1.4
1.2
—
—
—
0
0
30
359
0.81
0.47
1.2
1.3
0.46
7.30
u/ml
11.12
23
288
32
379
0.82
0.46
1.5
1.3
0.53
3.31
u/ml
3.69
26
283
14
103
1.36
0.44
1.0
1.0
19.90
19.29
mmol/l
0.34
14
103
14
103
1.36
0.44
1.0
1.0
—
—
—
0
0
30
354
0.82
0.42
1.2
1.3
0.07
1.34
u/ml
4.09
23
272
0
17
0.00
0.40
0.0
2.7
—
1.32
—
0
10
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
14
105
1.34
0.40
1.1
1.3
0.55
31.72
u/ml
—
9
90
5
36
1.38
0.38
1.0
3.6
—
219.52
—
0
10
7
51
1.37
0.31
4.6
1.6
—
—
—
0
0
30
258
1.17
0.30
1.4
1.2
1.82
2.73
u/ml
—
6
68
12
150
0.79
0.29
1.0
1.0
—
—
—
0
0
16
129
1.24
0.29
1.1
1.6
5.19
15.70
u/ml
0.47
11
92
17
139
1.22
0.28
2.6
1.8
6.46
6.30
ph
0.34
12
94
0
10
0.00
0.21
0.0
1.8
—
85.40
—
0
10
0
10
0.00
0.21
0.0
3.7
—
0.44
—
0
10
0
11
0.00
0.21
0.0
1.0
—
169.73
—
0
11
0
13
0.00
0.21
0.0
1.2
—
228.39
—
0
13
16
136
1.18
0.19
1.0
1.7
7.14
3.87
u/ml
0.29
11
102
5
45
1.10
0.09
1.0
1.1
—
—
—
0
0
15
137
1.09
0.06
1.3
1.1
—
—
—
0
0
14
148
0.93
0.03
1.3
1.2
—
—
—
0
0
50
484
1.03
0.03
1.4
1.5
—
367.08
—
0
24
138
1372
1.00
0.00
1.7
2.3
0.41
4.44
u/ml
6.64
18
217
14
134
1.04
0.00
1.4
1.2
—
—
—
0
0
16
162
0.98
0.00
1.6
2.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
2.8
—
48.40
—
0
5
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
61
0.97
-0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
385.83
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
9.23
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MIH_CARIES and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MIH_CARIES.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: K11_MIH_CARIES – Molar incisor enamel hypoplasia, with caries

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data